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People with refractory epilepsy suffer from important limitations that may have a severe 
impact on their personal, family and social functioning. Moreover, they have very high rates 
of mental disorders, often underdiagnosed and undertreated.  
In this thesis, we aimed to investigate the bidirectional relationship between refractory 
epilepsy and mental disorders. Psychiatrists´ interest in the study of mood and behavior of 
people with epilepsy dates back to many years ago. However, there is still need to 
systematize and add scientific evidence to many of the previous theories. We believe that by 
focusing on these matters we may bring important insights into both epilepsy and mental 
disorders.  
Our plan of work included two parts. First, we studied the impact of epilepsy-related factors 
and epilepsy surgery on mental disorders. Then, we focused on the impact of mental 
disorders on the course of epilepsy, after surgery. 
We believe that our research may have significant implications for both researchers and 
clinicians. The investigation of the factors that lead to the worsening or de novo psychiatric 
symptoms may contribute to unravel the neurobiological basis of mental disorders. The 
interconnection between Psychiatry and Neurosciences is, indeed, fundamental for the 
comprehension of psychiatric syndromes.  
Moreover, the study of the mutual relationship between these disorders will certainly help 
us to understand them better and how they could have a negative impact on each other. 
Finally, we hope that this work will also reinforce the importance of recognizing psychiatric 
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Although the relationship between mental disorders and epilepsy has been studied for several 
years there is a lack of systematization of knowledge in this area. People with epilepsy, 
particularly those who are refractory to pharmacological treatment, have a high prevalence 
of psychiatric comorbidities. For these patients, surgical treatment is often proposed; its 
effects at a psychopathological level may depend on the clinical characteristics of each 
person and the surgical technique itself. While some epilepsy-related characteristics may 
contribute to a higher risk of psychiatric disorders, these may also be associated with the 
prognosis of refractory epilepsy. 
 
Aims 
This study focused on the relationship between mental illness and refractory epilepsy. 
Specifically, our objectives were to study the mutual influence between refractory epilepsy 
or epilepsy surgery and mental disorders. Moreover, we also aimed to determine if the 
dysfunction, associated with the epilepsy origin, of a particular lobe or hemisphere 
influenced the risk or the type of any psychiatric disorder. 
 
Methods 
To investigate these questions, we designed one cross-sectional and five ambispective cohort 
studies, using a sample of people with refractory epilepsy referred to surgery. The 
participants were accessed before surgery and annually, after that, during a maximum period 
of three years, by a psychiatrist from the Epilepsy Surgery Group of Hospital de Santa Maria. 
Assessments included a clinical evaluation and a battery of scales and questionnaires. 
Different statistical approaches were used according to the aim of each study. 
 
Results 
Our results showed that 46% of people with refractory epilepsy had a lifetime history of 
some psychiatric disorder and the risk seems to be higher in those with an epilepsy originated 
in the right hemisphere. Regarding personality, 70% had a dysfunctional personality pattern. 
After epilepsy surgery, this percentage dropped to 58% and the difference was found to be 




temporal epilepsy origin while an extratemporal origin was associated with “Histrionic” and 
“Antisocial” patterns. 
Additionally, our studies allowed us to identify that epilepsy with a multilobar origin and a 
neuromodulation technique, the Deep Brain Stimulation of the Anterior Thalamic Nucleus 
(ANT-DBS) were associated with the development of de novo psychiatric disorders. 
It was also demonstrated that in people with a bilateral epilepsy origin, no remission of 
epileptic seizures and in those submitted to ANT-DBS there was an increase of 
psychopathological scores and, consequently, a greater mental suffering, one year after the 
epilepsy surgery. 
Regarding the course of refractory epilepsy, we showed that a history of any mental illness 
is a predictor of lower seizure control after surgery. In fact, regarding epilepsy surgery 
outcome this was the most important contributor to the accuracy of a predictive model. 
 
Conclusions 
Important conclusions can be drawn from these results. People with refractory epilepsy have 
high rates of mental disorders and dysfunctional personality adjustment patterns. Regarding 
the relationship with surgery, people who are subjected to ANT-DBS appear to have an 
increased probability of either developing new psychiatric syndromes or worsening previous 
psychopathological symptoms, when compared to conventional resective surgery. Despite 
the fact that this modality of neuromodulation is relatively recent, this work points to a high 
risk of psychiatric effects. 
Moreover, people with a bilateral or multilobar epilepsy origin also have higher risk of 
worsening or developing de novo psychopathology. Considering these data and our findings 
regarding the poor reduction after surgery of those with psychiatric disorders present, we 
hypothesize that there might be a subgroup of people with wider brain dysfunction, leading 
to a more serious neuropsychiatric disorder and therefore worse global prognosis.  
In summary, together these studies allowed us to demonstrate evidence for a bidirectional 
relationship between refractory epilepsy and mental disorders. Epilepsy-related factors 
affect the course of mental disorders and mental disorders affect the course of epilepsy after 
surgery. Similarly, we showed that epilepsy surgery also affects the future course of 
psychopathological symptoms and dysfunctional behavioural patterns. By demonstrating 
this relationship, our work emphasized the importance of a close collaboration between 




Moreover, we showed that the potential dysfunction of a particular zone of the brain, due to 
the epilepsy origin, may be associated with a higher risk for any mental disorder and an 
increased probability of developing certain dysfunctional personality characteristics. These 
findings may add to the investigation of the biological basis of mental illnesses. 
Future studies should use bigger samples to confirm our results regarding the 
psychopathological risks of epilepsy surgery, particularly, ANT-DBS, and explore the 
hypothesis of a subgroup of patients with a more generalized brain dysfunction and what are 
the neurobiological mechanisms involved in this dysfunction. 
 
 














Embora a relação entre as doenças mentais e a epilepsia seja estudada desde há vários anos, 
os dados existentes são ainda controversos e pouco sistematizados. Hippocrates (460-370 
BC), terá sido um dos primeiros autores a descrever a existência de perturbações 
psicopatológicas em pessoas com epilepsia. Já no século XX, Kraepelin (1923) caraterizou 
alguns destes quadros, tendo descrito quer alterações do humor, nomeadamente as “Disforias 
Periódicas” quer alterações da personalidade. De facto, estas foram alvo de estudo ao longo 
de décadas, tendo sido, mais tarde, descrita a síndrome de Gastaut-Geschwind que 
compreendia um conjunto de caraterísticas do comportamento interictal, designadamente, o 
aumento de preocupações morais, filosóficas e interesses religiosos, viscosidade, hipergrafia 
e ausência de sentido de humor. Em Portugal salienta-se o trabalho de Júlio de Matos (1884) 
acerca da “Loucura Epilética” e de Miguel Bombarda (1896) que se debruçou sobre o estudo 
desta entidade em “Lições sobre Epilepsia e as Pseudo-Epilepsias”. 
Estudos mais recentes têm mostrado que as pessoas com epilepsia, particularmente, as que 
sofrem de epilepsia refratária ao tratamento farmacológico, tem uma elevada prevalência de 
comorbilidades psiquiátricas. As patologias mais comuns são as Perturbações do humor e 
ansiedade embora também se encontrem taxas mais elevadas de outras patologias, como as 
perturbações psicóticas, quando é feita a comparação com a população geral. Estes doentes 
têm também um maior risco de suicídio, estando esta entre as principais causas de 
mortalidade precoce nestas pessoas. O impacto das doenças mentais na qualidade de vida 
destes doentes é muito significativo e alguns estudos parecem apontar, igualmente para a 
possibilidade de agravarem o curso da própria epilepsia. Contudo, as patologias do foro 
mental continuam a ser subdiagnosticadas ou, muitas vezes, não tratadas, nestes doentes. 
Às pessoas com epilepsia refratária é, muitas vezes, proposto um tratamento cirúrgico cujos 
efeitos a nível psicopatológico poderão depender das caraterísticas clínicas de cada pessoa e 
da própria técnica cirúrgica. Para além disso, existem diferentes técnicas cirúrgicas, com 
intuito curativo ou paliativo, que poderão ser aplicadas de acordo com critérios clínicos e 








Este trabalho focou-se no estudo da influência mútua entre a epilepsia refratária ou a cirurgia 
da epilepsia e a doença mental. Para além disso, pretendemos, ainda, esclarecer se a 
disfunção, relacionada com a origem da epilepsia, de um determinado lobo ou hemisfério se 




Para investigar estas questões, foram projetados um estudo transversal, com o intuito de 
caraterizar a amostra, e cinco estudos de coorte ambispectivos, usando uma amostra de 
pessoas com epilepsia refratária encaminhada para cirurgia. Os participantes recrutados a 
partir do Grupo de Cirurgia de Epilepsia do Hospital de Santa Maria, foram avaliados antes 
da cirurgia e anualmente, durante um período máximo de três anos, por um dos psiquiatras 
envolvidos na equipa multidisciplinar deste grupo. As observações incluíram uma avaliação 
clínica e as seguintes escalas e questionários: The Brief Psychiatric Rating Scale (BPRS); 
The Hamilton Depression Rating Scale (HDRS); The Hamilton Anxiety Rating Scale 
(HARS); The Beck Depression Inventory (BDI); The Montgmomery-Asberg Depression 
Scale (MADRS); The Symptoms Distress Checklist (SCL-90); The Millon Clinical Multiaxial 
Inventory-II (MCMI-II); The Temperament Evaluation of Memphis, Pisa and San Diego 
Autoquestionnaire (TEMPS-A); The Quality of Life in Epilepsy Inventory (QoLIE 31) e a 
The Wechsler Adult Intelligence Scale (WAIS-III). Em cada estudo foram utilizados e 
reportados dados de apenas alguns destes testes de acordo com o objetivo do mesmo. Foram 
também definidas janelas temporais diferentes em cada trabalho, adequadas ao propósito do 
mesmo e de acordo com os dados disponíveis. As perturbações psiquiátricas podem ser 
classificadas, de acordo com a sua relação temporal com as crises epiléticas como pre-ictais 
ou interictais, tendo a nossa pesquisa incidido sobre este último tipo. Neste trabalho não 
foram ainda incluídas perturbações consideradas como especificamente associadas à 
epilepsia como a disforia interictal pela sua falta de validação. 
A análise das variáveis em estudo foi feita através da utilização de métodos estatísticos 
adequados a cada objetivo.  







Os nossos resultados mostram que 46% das pessoas com epilepsia refratária tem história de 
pelo menos uma perturbação psiquiátrica, ao longo da sua vida, e o risco parece estar 
aumentado em pessoas com foco epileptogénico direito. Em relação à personalidade, 70% 
desta população apresentou um padrão disfuncional de personalidade. Depois da cirurgia, 
esta percentagem decresceu para 58% e a diferença foi estatisticamente significativa. Os 
padrões “Evitante” e “Compulsivo” associaram-se a uma origem epilética temporal e os 
padrões “Histriónico” e “Antissocial” a uma origem extratemporal. 
Para além disso, os nossos estudos identificaram como fatores associados ao 
desenvolvimento de patologia psiquiátrica de novo pós cirurgia, designadamente, a zona 
epileptogénica multilobar e a estimulação cerebral profunda do núcleo anterior do tálamo 
(ANT-DBS).  
Demonstrou-se, ainda, que nas pessoas com origem epilética hemisférica bilateral, sem 
remissão das crises epiléticas e naquelas submetidas a ANT-DBS houve um agravamento de 
índices psicopatológicos e, por conseguinte, um maior sofrimento mental, um ano após a 
cirurgia da epilepsia. 
Em relação ao curso da epilepsia, demonstrou-se que a existência de história de doença 
mental constitui um preditor de menor controlo das crises epiléticas pós cirurgia. De fato, 
em relação ao resultado da cirurgia de epilepsia, esse foi o fator que mais contribuiu para a 
precisão de um modelo preditivo do resultado da cirurgia. 
 
Conclusões 
Importantes conclusões podem ser retiradas destes resultados. Pessoas com epilepsia 
refratária têm elevada prevalência de doença mental e de padrões de personalidade 
associados a um funcionamento mal adaptativo. Fatores relacionados com a epilepsia, tais 
como a sua topografia de origem, podem contribuir para o aumento desta vulnerabilidade. 
Considerando a relação com a cirurgia, as pessoas sujeitas a ANT-DBS parecem ter uma 
probabilidade muito superior, quer de desenvolvimento de síndromes psiquiátricas de novo, 
quer de agravamento de sintomas psicopatológicos prévios, em relação à cirurgia ressetiva 
convencional. Embora esta modalidade de neuromodulação seja ainda recente, este trabalho 
aponta para um risco elevado de alterações psiquiátricas.  
Adicionalmente, doentes com disfunção mais global do sistema nervoso central, associados 




agravamento ou de desenvolvimento de psicopatologia de novo. Por outro lado, as pessoas 
com história de doença mental também não respondem de forma tão eficaz à cirurgia, 
mantendo mais crises, após o procedimento. Estes doentes podem constituir um subgrupo 
caraterizado por uma patologia neuropsiquiátrica de base mais grave. 
Em conclusão, este trabalho permitiu obter evidência acerca da existência de uma relação 
bidirecional entre a epilepsia e as doenças psiquiátricas. Demonstrou-se que alguns fatores 
relacionados com a epilepsia afetam o curso e tipo de doenças mentais nesta população e 
que a as doenças mentais afetam o curso da própria epilepsia. Também se demonstrou que a 
cirurgia da epilepsia interfere com o curso dos sintomas psicopatológicos e comportamentais 
após este procedimento. Deste trabalho conclui-se, ainda, que a disfunção de diferentes 
regiões cerebrais poderá contribuir para a emergência de patologia mental. 
Assim, enfatiza-se a importância de uma estreita colaboração entre neurologistas e 
psiquiatras no acompanhamento das pessoas com epilepsia refratária. Desta colaboração 
podem ainda ser apontados caminhos para a investigação das bases biológicas das doenças 
mentais.  
Estudos futuros, envolvendo amostras mais amplas, poderão confirmar o risco aumentado 
de desenvolvimento de novo ou agravamento de sintomas psiquiátricos associados à cirurgia 
da epilepsia e em particular à ANT-DBS. Deverá ainda ser confirmada a hipótese aqui 
colocada de um potencial subgrupo, caraterizado por uma disfunção mais generalizada do 
sistema nervoso central, associado quer à epilepsia refratária de pior prognóstico quer à 
doença mental, assim como, quais os potenciais mecanismos neurobiológicos que poderão 
estar na base desta disfunção.  
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The bidirectional relationship between mental disorders and, particularly, depression was 
suggested, twenty-six centuries ago, by Hippocrates (460-370 BC), when he wrote 
“melancholics become epileptics and epileptics melancholics”, proposing a reciprocal 
relationship between depression and epilepsy[1]. Not surprisingly, the interest of 
psychiatrists in epilepsy has a long history. In the XIX century, Esquirol (1772-1840) and 
Morel (1809-1873) described the tendency of people with epilepsy to social isolation and 
hyperreligiosity[2]. Kraepelin (1856-1926) explained, in 1923, what he considered to be the 
most common form of psychiatric disorders in these patients, the “Periodic Dysphorias”, 
which corresponded to changes in mood, with irritability being its cardinal symptom. 
Additionally, these patients could present depression, anxiety and less common 
“paradoxistic” euphoric mood states or delusional episodes that he considered to be merely 
their extension[3]. Kraepelin also suggested that people with epilepsy have certain 
personality characteristics, he described them as meticulous, slowed, circumstantial, labile, 
irritable, explosive and prone to religiosity[4]. Again, about 20 years later, Bleuler (1857-
1939) described the disorders of mood in people with epilepsy (PWE) according to 
Kraepelin´s conceptions[3]. Between 1973 and 1984, Norman Geschwind´s, an American 
neurologist, published an extensive amount of literature concerning interictal behavioral 
changes in temporal lobe epilepsy (TLE). What was latter called the Gastaut-Geschwind 
syndrome included increased religious interests, hypergraphia, increased aggression, higher 
moral and philosophical concerns, viscosity, and seriousness (lack of humor). The same 
author proposed that these characteristics resulted from a lesion stimulating the limbic 
system[5]. Later research using the questionnaire developed by Bear and Fedio[6] to 
evaluate these personality traits in people with TLE did not support the syndrome[7]. 
In Portugal, some important psychiatrists treated people with epilepsy and wrote about their 
psychiatric disturbances. Among of the most notable works are those of Julio de Matos 






Epilepsy and comorbid Mental Disorders 
 
It is estimated that around 25 to 50% of PWE suffer from at least one psychiatric 
comorbidity. In some groups, such as TLE and Refractory Epilepsy (RE) a prevalence of up 
to 80% has been reported[9]. Although there are some discrepancies in literature, the most 
common type of disorders seem to be mood disorders, particularly, major depression, and 
anxiety[10,11]. The previous work of a Portuguese researcher, Professor Doutor António 
Palha (1985), focused on the determination of the prevalence of psychiatric disorders in a 
sample of 90 people with epilepsy. He showed that 63,3% had a history of depressive 
symptoms, 32,2% had a history of psychotic symptoms and 13,3% patients had severe 
anxiety symptoms in the past[8]. There is also an increased risk of suicide, particularly in 
TLE, in patients submitted to surgical treatment and those with psychiatric 
comorbidities[12]. 
Mental disorders have an important impact on PWE quality of life, contributing to the global 
burden and disability associated with epilepsy[13]. In the last decades, psychiatrists were 
not always involved in the care of these patients and psychiatric disorders are largely 
underdiagnosed and undertreated in people with neurological disorders[14].  
Disturbances of mood and behavior may be defined according to if they have a temporal 
relationship with seizures as peri-ictal (pre-ictal, post-ictal and ictal) and, if no relation with 
seizure occurrence can be established, as interictal[15]. Our work focused on interictal 
disorders, as psychiatric comorbidities are generally considered.  
There has been some controversy regarding the atypical nature of some mental and 
behavioral disturbances in epilepsy. An example of this dissidence is the interictal dysforic 
disorder that has its roots on the syndrome defined by Kraepelin and Bleuler[16]. However, 
the majority of patients with this disorder also have depression and anxiety that seem to have 
a much higher impact on quality of life and seizure control[17]. Moreover, dysphoric 
disorder was never included in diagnostic classifications, it is considered doubtful, lacking 
diagnostic tools and clinical utility[17]. Other entities such as the interictal personality, 
formerly known as the Gastaut-Geschwind syndrome and the interictal psychosis were not 
proven to constitute well characterized and individual syndromes in epilepsy[18,19]. Instead 
they share common characteristics with the syndromes diagnosed by international 
classification systems, inherently polymorphic, in patients with and without epilepsy. 
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In our work, we choose not to include other entities rather than those that could be diagnosed 
according to the 10th version of the International Statistical Classification of Diseases and 
Related Health Problems (ICD-10) criteria. 
 
Underlying mechanisms and risk factors 
 
Risk factors for mental disorders in PWE include psychosocial factors such as stigma, poor 
disease acceptance, anticipatory anxiety associated with the unpredictable nature and 
outcome of seizures, as well as, the limitations imposed by the disease itself[20]. 
Pharmacological effects, related to the use of antiepileptics, should also be considered. These 
may originate from their mechanism of action, involving the regulation of neuronal 
excitability and potentially the modulation of the serotoninergic, noradrenergic and 
dopaminergic systems, neural plasticity and neurogenesis, the underlying neurological 
condition and personal factors[21].  
Epilepsy-related factors may, as well, contribute to the increased vulnerability for mental 
disorders in this population. Epileptogenic activity may induce local or global long-term 
brain disturbances that increase the risk for the development of psychopathological 
symptoms and syndromes. In animal models, rats showed a depressive-like pattern of 
behavior after an induced status epilepticus[22,23]. Additionally, the researchers showed a 
decrease in serotonin concentration, turnover and release in the hippocampus of these 
animals[24]. 
Neurobiological aspects may, in fact, constitute common underlying mechanisms in both 
epilepsy and psychiatric disorders or, alternatively, these disorders may represent different 
expressions of the same molecular substrates. These factors may include alterations in the 
neurotransmission mediated by serotonin, dopamine, norepinephrine, glutamate and γ-
aminobutyric acid (GABA) through changes in signal transduction mechanisms. Other 
suggested contributors are the hyperactivity of the hypothalamic–pituitary–adrenal axis and 
the central nervous system inflammation, occurring in both epilepsy and mental 
disorders[25]. 
Moreover, some studies have pointed out to a shared heritability between some mental 
disorders, such as, schizophrenia, attention deficit hyper-activity disorder, autism spectrum 
disorders and epilepsy[26,27].  
A commonly cited neurobiological phenomena, is forced normalization, a term coined by 
Landolt (1958) to explain psychotic symptoms associated with the disappearance of 
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epileptiform activity on electroencephalograms and seizure remission in PWE[28]. Since 
then, many clinical cases, corresponding to the initial description, have been reported and 
some potential explanatory mechanisms have been proposed as well. These include the 
ability of kindling, initiated by electrical stimuli applied to the mesolimbic system, to 
produce behavioral changes in animal models[29], and modulation of neurotransmitters such 
as dopamine, glutamate or GABA produced by antiepileptic drugs[28,30]. However, forced 
normalization is reported to occur only in 7.8% of PWE[31] and its biological mechanism 
remains largely unknown. 
Two other terms were proposed later: the term alternative psychosis, suggested by 
Tellenbach (1965), that applies to the clinical phenomenon of a reciprocal relationship 
between abnormal mental states and seizures that did not rely on EEG findings, and 
paradoxical normalization, suggested by Wolf (1991), describing epilepsy that is still active, 
but it remains subcortical and leads to the development of psychopathological 
symptoms[32]. 
People with psychiatric disorders also have an increased risk of developing epilepsy. Some 
psychiatric disorders such as attention deficit disorder with hyperactivity, major depression 
and suicidal ideation may precede the onset of epilepsy. Population-based studies found an 
increased risk of epilepsy from 3.5 to 17 times greater in patients suffering from psychiatric 
disorders when compared to the general population[33]. 
Additionally, mental disorders have been associated with clinical refractoriness in PWE[1].  
 
Refractory Epilepsy and Epilepsy Surgery 
 
In 2014, the International League Against Epilepsy (ILAE) defined epilepsy as “a disease of 
the brain defined by any of the following conditions: (1) at least two unprovoked (or reflex) 
seizures occurring >24 h apart; (2) one unprovoked (or reflex) seizure and a probability of 
further seizures similar to the general recurrence risk (at least 60%) after two unprovoked 
seizures, occurring over the next 10 years; (3) diagnosis of an epilepsy syndrome”[34].  
About 60% of PWE have a focal-onset epilepsy, affecting, most frequently, the temporal 
lobe[35]. Neocortical TLE represents 10% of TLEs and the rest affects mesial structures – 
the hippocampus and the amygdala[36,37].  
About a third of PWE do not respond to pharmacological treatment[38] and are considered 
to have RE. This is defined as “failure of adequate trials of two tolerated, appropriately 
chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) 
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to achieve sustained seizure freedom”[39]. An even higher prevalence of psychiatric 
disorders has been reported in these patients[40,41]. The potential to lower seizures 
threshold of some psychotherapeutic drugs such as antidepressants or antipsychotics, as well 
as structural and functional brain abnormalities and dysfunctional secretion of 
neurotransmitters, in both pharmacoresistant epilepsy and psychiatric disorders, have been 
proposed as potential mechanisms underlying this association[42]. 
Patients with RE may be eligible for resective surgery, a procedure that is effective in the 
remission of seizures in about 70% of the cases[43]. However, seizure control may depend 
on several clinical factors including age at surgery, duration of epilepsy and location of the 
area of the cortex that is necessary and sufficient for initiating seizures and whose removal 
(or disconnection) is necessary for complete abolition of seizures, called the epileptogenic 
zone[44–46].  
For those whom, by any reason, surgical resection is not feasible, other options may be 
considered. Namely, neuromodulation interventions, such as Vagus Nerve Stimulation 
(VNS) or Deep Brain Stimulation, targeting the Anterior Nucleus of the Thalamus (ANT-
DBS)[47]. These are palliative procedures with much lower rates of success.  
The standard method to report the outcome of epilepsy surgery is the Engel Scale (Table 
1)[48]. This instrument was developed by the neurologist Jerome Engel Jr. and was first 
presented at the Palm Desert Conference on Epilepsy Surgery in 1992[49].  
All these techniques have shown positive results in the reduction of seizure frequency, while 
the resection of the epileptogenic zone is curative.  
Although the procedure seems to have a global positive effect also in terms of quality of life 
and psychopathology, particularly in those who became seizure-free[50–53], these results 
are still controversial[11,54,55] and up to 20% of these patients may develop de novo 
psychiatric disorders[56]. Differences between studies might be due to the selection of small 
and different patient samples. 
Establishing clinical factors related to both psychiatric and neurological outcomes, after 
epilepsy surgery, plays an important role in the determination of psychopathological risks 
and success of surgery. The knowledge of potential success and risks are fundamental to 
inform both patients and clinicians regarding their decision to proceed to such an invasive 
procedure. This knowledge also helps to identify patients that might need more frequent 
psychiatric routine assessments and vigilance. 
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Furthermore, the research of biological factors associated with specific psychiatric disorders 
or the general risk for their emergence or aggravation may help to define investigation lines 
regarding the neurobiological basis of psychiatric disorders. 
 
Table 1 - Engel's Classification of Postoperative Outcome 
 
Class I: Free of disabling seizuresa 
 A. Completely seizure free since surgery 
 B. Nondisabling simple partial seizures only since surgery 
 C. Some disabling seizures after surgery, but free of disabling seizures for at 
least 2 years 
 D. Generalized convulsions with AED discontinuation only 
Class II: Rare disabling seizures (“almost seizure free”) 
 A. Initially free of disabling seizures but has rare seizures now 
 B. Rare disabling seizures since surgery 
 C. More than rare disabling seizures since surgery, but rare seizures for the last 2 
years 
 D. Nocturnal seizures only 
Class III: Worthwhile improvementb 
 A. Worthwhile seizure reduction 
 B. Prolonged seizure-free intervals amounting to greater than half the followed-
up period, but not <2 years 
Class IV: No worthwhile improvement 
 A. Significant seizure reduction 
 B. No appreciable change 
 C. Seizures worse 
a Excludes early postoperative seizures (first few weeks).  
b Determination of “worthwhile improvement” will require quantitative analysis of additional data 








Our aims were: 
• To study the effect of refractory epilepsy and epilepsy surgery on mental disorders. 
• To study the effect of mental disorders on the course of refractory epilepsy after 
surgery. 
• To explore the role of different brain areas on the susceptibility for psychiatric 

















THE STUDY SAMPLE 
 
This work was developed using a consecutive sample of people with refractory epilepsy 
referred to psychiatric pre-surgical evaluation by the Epilepsy Surgery Group of the Hospital 
de Santa Maria (CHULN), Lisbon, Portugal. It included people with temporal and 
extratemporal epileptogenic zones submitted to different surgical techniques (RS, VNS and 
ANT-DBS). 
Patients were accessed before surgery and 6, 12, 24, 36 and 60 months, after surgery. 
Collection of data has begun in 1999 and the design of this study was conceived in 2015. 
Therefore, a retrospective and a prospective component were considered.  
All assessments were made by a psychiatrist and a psychologist from the Epilepsy Surgery 
Group and included a full clinical evaluation and the following instruments adapted from 
the 1st Steering Committee Meeting Epilepsy Registry:  
• The Brief Psychiatric Rating Scale (BPRS);  
• The Hamilton Depression Rating Scale (HDRS);  
• The Hamilton Anxiety Rating Scale (HARS);  
• The Beck Depression Inventory (BDI);  
• The Montgmomery-Asberg Depression Scale (MADRS); 
• The Symptoms Distress Checklist (SCL-90);  
• The Millon Clinical Multiaxial Inventory-II (MCMI-II);   
• The Temperament Evaluation of Memphis, Pisa and San Diego Autoquestionnaire 
(TEMPS-A); 
• The Quality of Life in Epilepsy Inventory (QoLIE 31);  






CLINICAL SCALES AND QUESTIONNAIRES  
 
Each study involved different data regarding clinical diagnosis and some of the tests and 
questionnaires, included in the initial battery, according to the objective of the study and the 
availability of data. Following is a description of those that were included: 
 
The Hamilton Anxiety Rating Scale (HARS) 
This rating scale is one of the first being developed to measure severity of anxiety symptoms 
and is nowadays one of the most widely used. The scale consists of 14 items and measures 
both phobic anxiety and somatic anxiety[57]. 
 
The Hamilton Depression Rating Scale (HDRS) 
This is the most widely used rating scale used to access depression. The version used 
corresponds to the original 17 items version. It was developed to access depression 
symptoms over the past week. The original scale was developed for inpatients and has a 
particular focus on melancholic an physical symptoms[58].  
 
Brief Psychiatric Rating Scale (BPRS) 
This rating scale is one of the most widely used scales to measure longitudinal changes in 
psychotic symptoms and it is based on the interview with the patient, his speech and 
behavior. The scale contains 18 items, each one rated from 1 (absente) to 7 (extremely 
severe), evaluating positive, negative and affective symptoms[59]. An extended Portuguese 
version, with 24 items, was adapted by Gusmão, Talina, Xavier and Caldas de Almeida 
(1996)[60]. 
 
Symptom Cheklist-90 (SCL-90) 
This multi-dimensional instrument is a 90-item self-report symptom inventory developed to 
measure psychological symptoms and psychological distress. It has been extensively 
validated and used in neurological patients. It contains 9 subscales evaluating different 
symptom dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, 
depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism. There are 
also three global indices for the SCL-90: 1) Global Severity Index (GSI), which is the 
average score of the 90 items of the questionnaire, 2) Positive Symptom Distress Index, 
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which is the average score of the items scored above zero, and 3) Positive Symptoms Total, 
which is the number of items scored above zero[61]. The GSI is suggested to be the best 
single indicator of the current level of the disorder. A Portuguese version was made has been 
adapted from the revised version of this questionnaire and shown good psychometric 
results[62]. 
 
 The Millon Clinical Multiaxial Inventory II (MMCI-II) 
The MCMI-II is a psychological assessment toll used to evaluate personality patterns and 
psychopathology in adults. It includes 13 personality scales and 9 clinical syndrome 
scales[65]. This questionnaire was developed to evaluate personality prototypes that were 
included in the Diagnostic and Statistical Manual (DSM). For each personality type patient´s 
raw scores are converted into Base Rate scores. The presence of a personality trait is 
indicated by a score of 75 to 84 and a score of 85 or above indicates the persistence of a 
personality pattern. This version has been validated in clinical samples showing good 
internal consistency[66]. 
 
The Wechsler Adult Intelligence Scale (WAIS-III) 
This is a widely used Intelligence Quotient (IQ) test designed to measure intelligence and 

















RESEARCH QUESTIONS AND RESEARCH OUTLINE  
 
In order to achieve these objectives, six different studies were conceived to answer the 
following research questions: 
 
STUDY 1 
Question 1: What is the percentage of people with refractory epilepsy that also have a 
history of any mental disorder? 
Question 2: What are the most frequent psychiatric disorders in people with refractory 
epilepsy? 




Question 4: What is the percentage of people with a dysfunctional personality pattern in 
those with refractory epilepsy? 
Question 5: Does the affection of different brain lobes contribute to different types of 
personality disorders?  
Question 6: Is the epilepsy surgery associated with a reduction on the proportion of people 
with dysfunctional personality patterns? 
 
STUDY 3 
Question 7: What is the percentage of people developing de novo psychiatric disorders after 
epilepsy surgery? 
Question 8: Are there any epilepsy or surgery-related factors that could increase the risk for 
de novo disorders? 
 
STUDY 4 
Question 9: Considering those who already had some degree of psychiatric symptomatology 
are there any factors that could predict the worsening or the improvement of 






Question 10: Does a lifetime history of any psychiatric disorder predicts worse epileptic 
seizures control after surgery?  
 
STUDY 6 
Question 11: What is the relative importance of having a history of any psychiatric disorder 
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Abstract 
Objectives  The aim of this study was to determine the rate and types of lifetime 
psychiatric disorders, as well as their predictors, in a sample of people with 
refractory epilepsy.  
Methods  Demographic, neurological, psychiatric and neuropsychological data, from 
people with refractory epilepsy, were registered at the pre-surgical interview. 
Logistic regression was used to determine predictors. 
Results  One hundred and ninety-one participants were included. Forty-six percent of 
our sample had at least one previous psychiatric diagnosis, most frequently 
depressive (64%), anxiety (10%), substance use (10%) and psychotic 
disorders (6%). Patients with a right-side epileptogenic zone had an increased 
risk for these disorders (OR 2.36; CI 1.22-4.56; p=0.01). 
Conclusion  Specific epilepsy-related factors may raise the risk of developing a 
psychiatric disorder. Our study adds evidence to support a bidirectional 
relationship between epilepsy and mental health. 
 









People with epilepsy and particularly those with medically refractory epilepsy have an 
increased risk of mental disorders and suicide[68,69]. Additionally, psychiatric disorders 
and their treatment may also increase the risk of developing epilepsy[70,71].  
Lifetime psychiatric disorders have been reported in more than 50% of people with 
refractory epilepsy[72,73]. The most common disorders, in this population, are depression 
(24-74%), anxiety disorders (10-25%) and psychotic disorders (2-7%)[73].  
Psychiatric comorbidity worsens the quality of life[74] of these people and has a negative 
impact on the course of epilepsy both before[75] and after epilepsy surgery[76]. In fact, 
according to the new definition of epilepsy, this is not only a disease with recurrent seizures 
but it is also often associated with cognitive and psychiatric comorbidities[77]. 
Some factors that may contribute to the high prevalence of psychiatric comorbidities in 
epilepsy have been proposed. They include psychosocial adverse factors such as stigma and 
discrimination,  
mobility issues and lack of employment opportunities[78]. 
Little is known about biological risk factors for the development of psychiatric disorders in 
the context of epilepsy, however, some mechanisms, mainly based on research in animal 
models, have been proposed. Some are common aspects of both epilepsy and mental 
disorders, particularly, depression, and comprise hypothalamic–pituitary–adrenal axis 
hyperactivity, decreased serotonergic neurotransmission and noradrenergic 
neurotransmission, glutamatergic and GABAergic disturbances and inflammatory 
processes[79].  
Other factors associated with a higher risk of psychiatric disorders in people with epilepsy 
include malformations of cortical development[80], accumulation of seizure-related 
damages related to higher number of previous seizures[81], earlier age at epilepsy onset[82], 
involvement of potentially more sensitive areas and structures such as the those located in 
the temporal lobe[83] and the use of antiepileptic drugs[84]. 
Despite the probable important contribution of psychosocial considerations, as epilepsy 
directly affects the central nervous system, we may assume that some factors related to this 
direct brain insult may increase the risk of developing psychopathological symptoms.  
The aims of this study were the characterization of lifetime psychiatric disorders, in patients 
with refractory epilepsy, particularly, their prevalence and types, and also to identify 





2. Methods  
People with refractory epilepsy were recruited, between April 2000 and September 2018, 
from the Refractory Epilepsy Reference Centre and the Epilepsy Surgery Group from the 
Department of Neurosciences and Mental Health of our Institution. The diagnosis of 
refractory epilepsy was made according to the International League Against Epilepsy[85]. 
For the purpose of this study, we included the presurgical evaluation data from people with 
temporal and extratemporal epileptogenic zones. This assessment included a video-
electroencephalography (EEG) monitoring, a 3-Tesla brain magnetic resonance with 
epilepsy protocol, functional magnetic resonance imaging (fMRI) and positron emission 
tomography scans to determine the epileptogenic zone, a neuropsychological and a 
psychiatric evaluation.  
This study has been performed in accordance with the ethical standards of the 1964 
Declaration of Helsinki and its later amendments and was approved by the Ethics Committee 
of our institution.  
 
2.1 Subjects 
Participants older than 18 years, with refractory epilepsy were included. Those with other 
neurological diseases or intellectual disability were excluded from the analysis. 
Demographic (gender, age, employment status, marital status) and clinical data (etiology of 
epilepsy, the topography of the epileptogenic zone, the age of onset, time to surgery as well 
as other relevant data) were collected during interviews and from medical and surgical 
records at the time of the pre-surgical evaluation.  
 
2.2 Psychiatric Evaluation 
Each patient was subjected to a psychiatric evaluation made by an experienced psychiatrist, 
from our group and center, and included a clinical psychiatric history (demographic data, 
previous psychiatric history, family history, use of substances as well as other relevant data) 
collected at the presurgical evaluation. Information from the patient, accompanying person 
and medical records were taken into consideration. 
 
2.3 Statistical Analysis  
The statistical analysis was made using Stata software (version 14.2; StataCorp, Texas, 
USA). Descriptive statistics were performed to report the analysis of data presented as mean 
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± standard deviation or median (minimum-maximum). Student's t-test and the Mann-
Whitney U test were used for parametric and non-parametric data, respectively. A chi-square 
test, or the Fisher exact test in case of non-parametric data, was applied to compare 
categorical variables which were given as the number of cases and proportions.  
Using forward selection, each predictor was tested using a logistic regression model and then 
significant predictors were included in a multivariate model. These variables include age, 
gender, duration of epilepsy, age of epilepsy onset, location of the epileptogenic focus 
considering the lobe and lateralization. Within patients with temporal epilepsy, neocortical 
versus mesial location were also included. 
Measures of association were expressed as Odds Ratio (OR) and a p-value ≤0.05 was 
considered statistically significant. 
 
3 Results 
3.1  Demographic and clinical findings. 
Two hundred and four consecutive people with RE who were proposed to pre-surgical 
evaluation were enrolled. Five were secondarily excluded because of intellectual disability, 
and 1 refused to participate. Thus, a total of 199 individuals were included in the sample. 
Their demographic and clinical characteristics were illustrated in Table 2. Considering the 
excluded patients: four had left temporal epileptogenic zones, one had a right temporal 
epileptogenic zone, and one had a right occipital epileptogenic zone. There was missing 
information regarding the epileptogenic zone of 8 patients (4%). We assumed this 
information was missing completely at random and excluded it from the analysis.  
 
Table 2 - Socio-demographical and clinical characteristics of the participants.  
AGE, YEARS 38.8 ± 11.6 
MALES, N (%) 85 (42.7) 
EDUCATION, YEARS 10.1 ± 4.5 
ACTIVE WORKERS, N (%) 93 (64.6) 
UNEMPLOYED, N (%) 39 (21.7) 
RETIRED, N (%) 25 (13.9) 
MARRIED, N (%) 74 (50.0) 
AGE AT ONSET, YEARS 15.9 ± 11.3 
DURATION OF EPILEPSY, YEARS 22.7 ± 13.0 
TEMPORAL EPILEPTOGENIC ZONE, N (%) 168 (86.6) 
• MESIAL, N (%) 134 (82) 
• NEOCORTICAL, N (%) 29 (18) 
EXTRATEMPORAL EPILEPTOGENIC ZONE, N (%) 26 (13.4) 
• FRONTAL EPILEPTOGENIC ZONE, N (%) 13 (6.7) 
• MULTILOBAR EPILEPTOGENIC ZONE, N (%) 10 (5.2) 
• OCCIPITAL EPILEPTOGENIC ZONE, N (%) 2 (1.0) 
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• PARIETAL EPILEPTOGENIC ZONE, N (%) 1 (0.5) 
SIDE OF THE EPILEPTOGENIC FOCUS  
• LEFT 97 (50.8) 
• RIGHT 84 (44.0) 
• BILATERAL 10 (5.2) 
NUMBER OF ANTIEPILEPTIC DRUGS 2.3 (0.6) 
 
 
3.2  Lifetime psychiatric diagnosis 
Seventy-seven people (46%) from our sample were found to have at least one-lifetime 
psychiatric diagnosis. Among these patients, the most frequent psychiatric disorders were 
depressive (64%), anxiety (10%), substance abuse (10%) and psychotic disorders (6%).  
 
3.3 Results from the logistic regression model 
Right side epileptogenic zone was a significant predictor of a lifetime psychiatric diagnosis 
(Crude analysis: OR 2.36; CI 1.22-4.56; p=0.01; Adjusted analysis: OR 2.33; CI 1.17-4.63; 
p=0.02), independently of the epileptogenic lobe. 
Patients with a right-sided epileptogenic zone had increased rates of depression (35% versus 
24%), anxiety disorders (7% versus 1%) and psychotic disorders (6% versus 1%). 
The other variables tested were not found to constitute significant predictors. 
The full results from the logistic regression model are represented in Table 3.  
 
Table 3 - Results from the logistic regression model. 
PREDICTORS OR STANDARD ERROR P 
Age 1.03 0.02 0.120 
Gender 0.55 0.20 0.097 
Age at onset 0.99 0.02 0.829 
Duration of epilepsy 1.00 0.02 0.979 
Temporal epileptogenic zone, n (%) 1.22 1.22 0.839 
Extratemporal epileptogenic zone, n (%) 1.90 2.12 0.563 
Multilobar epileptogenic zone, n (%) 0.82 0.81 0.839 
Side of the epileptogenic focus 
• Left 0.43 0.15 0.016 
• Right 2.33 0.82 0.016 
• Bilateral 1.62 1.37 0.570 
 
4 Discussion 
In our sample, forty-six percent of people had a past history of at least one previous 
psychiatric disorder. In this order, depressive, anxiety, substance use, and psychotic 
disorders were the most frequent types of diagnosis. 
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Studies focusing on the prevalence of psychiatric disorders in people with refractory epilepsy 
report different prevalence rates, probably, because of differences in the diagnostic criteria 
and methods and different people samples. However, they all tend to report an increased rate 
when compared to the general populations and with individuals presenting other 
neurological or non-neurological conditions[86].  
Moreover, our work shows that people with a right epileptogenic zone have more than twice 
the risk (OR 2.33) of having a psychiatric disorder compared to those with a left 
epileptogenic zone. In our sample, people with a right-side epileptogenic zone had increased 
rates of depression, anxiety, and psychosis when compared to left or bilateral epileptogenic 
focus. This risk is independent of the affected lobe and other demographic and clinical 
factors related to epilepsy. 
Our findings are in line with previous studies, both in epilepsy and in other neurological 
disorders. Sperli et al. (2009) found that a right side epileptogenic zone was a risk factor for 
psychiatric comorbidity[87]. More recently, Jansen et al. (2018) also found that people with 
right-sided epilepsy had a more frequent history of psychiatric disorders prior to epilepsy 
onset[88]. 
The right hemisphere has a major role in emotion processing[89], including visuospatial 
attention and emotional perception, recognition memory for emotional images[90] and facial 
emotion processing[91]. While some studies suggest that it may have a preponderant role on 
the processing of negative stimulate, others state that there is a general dominance of the 
right hemisphere for all emotions, regardless of their affective valence[92,93]. 
There is an association between right side stroke and depression[94]. Moreover, 
neuroimaging studies suggest that the right hemisphere has important involvement in 
depression[95,96]. Right hemisphere function deficits, symmetry breaking, and more 
random network structure were found in depressive disorders[97]. Therefore, an 
epileptogenic insult located in this hemisphere may disrupt important networks involved in 
this function, probably even before the epileptic seizures manifest clinically. 
Besides depression, research in other neurological disorders showed that post-stroke 
psychosis, most frequently, follows unilateral damage of the right hemisphere[98,99]. 
Bilateral or right traumatic lesions were associated with delusional disorders[100]. It has 
been suggested that the right hemisphere might have a role in the production of delusional 
beliefs as it has important roles in pragmatic communication, perceptual integration, 
attentional surveillance, and anomaly/novelty detection and belief updating[101]. 
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Both primary and secondary psychosis respond to antipsychotics suggesting a common 
underlying pathological mechanism[98,99]. 
Research on anxiety and laterality is still scarce, however, recent research showed that the 
right hemisphere may have a key role in the neuroanatomical basis of Generalized Anxiety 
Disorder[102]. 
This study has some limitations. The first was that this was an observational study, with a 
retrospective component. Different sources of information were considered in order to 
confirm clinical information and to reduce missing data. Second, as this is a transversal study 
so causality cannot be determined. Third, lifetime psychiatric disorders may be 
underestimated because they may be seen as a natural reaction to epilepsy and its limitations, 
they may not be remembered or be underreported because of the fear of not qualifying for 
surgery. However, previous clinical reports and family members were consulted to reduce 
this possibility. Forth, the type of antiepileptic drugs was not controlled and these may have 
an impact on mood and behavior. Nevertheless, we do not expect to have significant 
differences in therapeutic schemes between people with different epileptogenic focus as they 
are mainly determined by their efficacy on the control of epilepsy, regardless of the 
epileptogenic zone. There were no significant differences in the number of antiepileptics 
between people with and without previous psychiatric comorbidity.  
Notwithstanding these limitations, our results point out important conclusions. Psychiatric 
comorbidity is much more frequent in people with refractory epilepsy than in the general 
population and those with a right epileptogenic zone may be at a higher risk.  
These data support the bidirectional relationship between epilepsy and mental health. It may 
also add to the current knowledge of the neurobiological basis of psychiatric disorders. 
Future studies should focus on the biological mechanism that may explain this association 
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Abstract 
Objectives  The aims of this study were to determine the rate of dysfunctional personality 
patterns before and after epilepsy surgery, their types and the importance of 
the epileptogenic zone in a sample of people with refractory epilepsy.  
Methods  We conducted an ambispective observational study, including refractory 
epilepsy surgery candidates. Demographic, psychiatric and neurological data 
were recorded. Evaluation of personality was made using the Millon Clinical 
Multiaxial Inventory-II (MCMI-II). Pre-surgical predictors of personality 
patterns were determined using a logistic regression model. The proportion 
of patients with dysfunctional personality patterns, before and after surgery, 
was compared using the Mcnemar´s test. Then a generalized estimating 
equation model was performed to include predictors of changes in this rate.  
Results  One hundred and ninety-nine participants were included. Seventy percent had 
a dysfunctional personality pattern before surgery. After surgery, this 
percentage dropped to 58%. The difference was statistically significant after 
adjusting for potential confounders (p=0.013). The most common types were 
Cluster C personality patterns. Temporal epileptogenic zone was a significant 
predictor of higher scores of the Avoidant (Coef. 11.8; CI -0.59 23.7; 
p=0.051) and Compulsive (Coef. 9.55; CI 2.48 16.6; p=0.008) personality 
patterns and lower scores of Histrionic (Coef. -11.4; CI -21.2 -1.55; p=0.024) 
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and Antisocial (Coef. -8.4; CI -15.6 -1.25; p=0.022) personality patterns, 
compared to extratemporal epileptogenic zone. 
Conclusion  People with refractory epilepsy have high rates of dysfunctional personality 
patterns. These patterns differ according to the epileptogenic zone.   
 




The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) defines 
personality disorder as “an enduring pattern of inner experience and behavior the deviates 
markedly from the expectations of the individual's culture”[103]. This pattern includes 
impairments in personality (self and interpersonal) functioning and the presence of 
pathological personality traits, defined as habitual forms of behavior, thought, and emotion 
that is relatively stable across time and consistent across situations, in each individual[104]. 
The DSM-5 defines a set of ten types of personality disorders, each one defined by a typical 
group of dysfunctional personality characteristics or traits. Personality traits, including 
pathological traits, such as grandiosity, obsessionality, impulsivity or emotional lability, 
exhibit much higher rates of stability than personality disorders[105]. Personality disorders 
are organized into 3 clusters:  Cluster A (odd/eccentric), including Paranoid, Schizoid, and 
Schizotypal personality disorders; Cluster B (dramatic/emotional/erratic), including 
Antisocial, Borderline, Histrionic, and Narcissistic personality disorders; and Cluster C 
(anxious/fearful), including Obsessive–Compulsive, Avoidant, and Dependent personality 
disorders[106].  
The high prevalence of dysfunctional personality traits among people with epilepsy was 
noted many decades ago and it has been discussed over the years. Kraepelin(1923) described 
certain distinctive personality characteristics in these patients, such as meticulousness, 
slowness, circumstantiality, lability, irritability, explosiveness and a particular proneness to 
religiosity[4]. Between 1973 and 1986, Norman Geschwind wrote substantially about what 
was later called the “Geschwind syndrome”, in people with temporal lobe epilepsy (TLE). 
It included increased religious interests, hypergraphia, increased aggression, increased 
moral and philosophical concerns, viscosity, and seriousness. He also provided an 
explanation based on the effect of a lesion stimulating the limbic system[5].  
Nowadays, some authors still consider the existence of an “interictal personality” in TLE, 
historically defined as a seizure-based behavioral condition which includes the traits 
described by Geschwind and it is assessed using the Neurobehavioral Inventory (NBI)[107]. 
However, this entity is still controversial and it has not been included as a specific type of 
personality disorder in the standard psychiatric classifications[108,109].  
Personality traits and personality disorders have been investigated independently in epilepsy. 
Recent research has shown that people with epilepsy have certain personality characteristics 
or traits, such as lower self-consideration and self-esteem[110]. Some personality traits may 
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be associated with epilepsy-related factors, namely, earlier age of onset, longer duration of 
epileptic history and higher seizure frequency[111]. 
Regarding personality disorders, diagnosed according to the DSM or the International 
Statistical Classification of Diseases and Related Health Problems (ICD), their prevalence 
ranges between 13 to 35% in people with focal epilepsy (mainly TLE), and from 18 to 42% 
in surgical candidates or people who have undergone surgery[112]. In comparison, the 
prevalence of personality disorders in the general population ranges between 4 and 
15%[113]. The most prevalent types are not consensual amongst studies. However, cluster 
C personality disorders, namely Obsessive-Compulsive, Dependent and Avoidant are 
commonly cited as the most frequent in samples of people with refractory epilepsy[114–
116]. 
Personality disorders in people with epilepsy have been associated with the adaptation or 
reaction to psychosocial factors, such as stigmatization, low self-esteem or social 
isolation[112] but also to epileptic seizure-related factors including a temporal epileptogenic 
zone, earlier age of onset, longer duration of the disease and higher seizure frequency[111]. 
Moreover, personality disorders may also have an impact on the course of epilepsy, 
potentially affecting adherence to treatment and interpersonal behavior in medical 
settings[112]. People with preoperative personality disorders also seem to be less likely to 
become seizure-free after temporal lobe resection[116]. 
The association of specific personality patterns to the epileptogenic zone and the role of 
surgery on the longitudinal course of these patterns have not been clearly established. With 
this study, we aimed to determine the rate of dysfunctional personality patterns and their 
types in a sample of people with refractory epilepsy. We also searched for epilepsy-related 
factors associated with these patterns. Finally, we aimed to evaluate the impact of surgery 
on the rate of these disorders. 
 
2. Methods  
This ambispective cohort study was conducted at the Department of Neurosciences and 
Mental Health of our Institution, between April 2000 and September 2018. Subjects were 
recruited from our Refractory Epilepsy Reference Centre and the Epilepsy Surgery Group. 
The diagnosis of refractory epilepsy was made according to the International League Against 
Epilepsy [85]. 
The presurgical evaluation included a video-electroencephalography (EEG) monitoring, a 
3-Tesla brain magnetic resonance with an epilepsy protocol, functional magnetic resonance 
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imaging (fMRI) and positron emission tomography scans to determine the epileptogenic 
zone, a neuropsychological and a psychiatric evaluation. People with temporal and extra-
temporal epileptogenic zones were included.  
Demographic (gender, age, employment status, marital status) and clinical data (etiology of 
epilepsy, the topography of the epileptogenic zone, the age of onset, time to surgery and 
Engel Class[48]) after surgery, were collected during interviews and from medical and 
surgical records. Participants were receiving a minimum of two antiepileptic drugs. 
However, the type and dosages of these drugs were not addressed in this study because there 
was considerable variability between patients, as it is usual in people with refractory 
epilepsy.  
This study has been performed in accordance with the ethical standards of the 1964 
Declaration of Helsinki and its later amendments and was approved by the Ethics Committee 
of our institution.  
 
2.1 Subjects 
Participants older than 18 years, with refractory epilepsy, included as surgery candidates, 
with at least one year of primary school education were included in the study. Those with 
other neurological diseases or intellectual disability were excluded from the analysis.  
 
2.2 Psychiatric Evaluation 
A psychiatric evaluation was performed by an experienced psychiatrist, before surgery and 
one year after the procedure. It included a clinical psychiatric history (demographic data, 
previous psychiatric history, family history, use of substances as well as other relevant data), 
the determination of a clinical diagnosis of lifetime and current psychiatric disorders, 
established according to the ICD-10[117], and the following personality and 
psychopathological tests:  
 
2.2.1 The Millon Clinical Multiaxial Inventory-II (MMCI-II)  
The MCMI-II is a psychological assessment tool used to evaluate personality patterns and 
psychopathology in adults. It includes 13 personality scales, 9 clinical syndrome scales[65] 
and three validity scales to assess response styles on the instrument[118]. This self-report 
questionnaire includes 175, yes or no questions, regarding patterns of emotional, cognitive 
and behavioral response. It was developed to evaluate personality prototypes that were 
included in the Diagnostic and Statistical Manual (DSM). However, as this is not a 
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standardized diagnostic instrument based on DSM diagnostic criteria, we opt to use the more 
conservative term of "personality patterns" to designate the dysfunctional personality types 
that it evaluates. For each personality type, the patient’s raw scores are converted into Base 
Rate scores. The presence of a personality trait is denoted by a score of 75 to 84 and a score 
of 85 or above indicates the persistence of a personality pattern. This version has been 
validated in clinical samples showing good internal consistency[66].  
 
2.2.2 The Hamilton Anxiety Rating Scale (HARS) 
The scale consists of 14 items and measures both psychic and somatic anxiety[57]. 
It is scored according to the following cut-offs: 17 = mild; 18-24 = mild to moderate; 25-30 
= moderate to severe anxiety[57].  
 
2.2.3 The Hamilton Depression Rating Scale (HDRS) 
The version used corresponds to the original 17 items version. It was developed to access 
the severity of depressive symptoms[58] and the following scores are generally considered: 
0-7 = normal; 8-16 = mild; 17-23 = moderate; >24 = severe depression[119]. 
 
2.3 Statistical Analysis  
The statistical analysis was performed using Stata software (version 14.2; StataCorp, Texas, 
USA). Descriptive statistics were performed to report the analysis of data presented as mean 
± standard deviation or median (minimum-maximum).  
For the study of the predictors, before surgery, the outcome variables were the types of 
personality patterns according to the MCMI-II, analyzed as continuous variables. For the 
purpose of this study, the psychopathological scales of MCMI-II were not integrated into the 
analysis. Predictors included the side of the epileptogenic zone, as a categorical variable 
(right, left or bilateral), the epileptogenic zone lobe, analyzed as a binary variable (temporal 
versus extratemporal). Within people with a temporal lobe epileptogenic zone, mesial versus 
neocortical zones were also included, as a binary variable. A linear regression model was 
used for the analysis. 
The McNemar’s test was first used to compare the proportion of patients with a score above 
85 at any personality pattern before and after surgery.  
Then, to study the longitudinal changes, according to different predictors and potential 
confounders, a generalized estimating equation model was used including the following 
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variables: type of surgery and Engel class, as binary variables; HDRS and HARS scores, 
obtained at the one-year evaluation, as continuous variables. 
Measures of association were expressed as Coefficients or Odds-Ratio (OR) and a p-value 
≤0.05 was considered statistically significant. 
 
3 Results 
3.1  Demographic and clinical findings 
One hundred and ninety-nine participants were included in the sample. Their demographic 
and clinical characteristics are illustrated in Table 4.  
 
Table 4 - Socio-demographical and clinical characteristics of the participants. 
AGE, YEARS 38.8 ± 11.6 
MALES, N (%) 85 (42.7) 
EDUCATION, YEARS 10.1 ± 4.5 
ACTIVE WORKERS, N (%) 93 (64.6) 
UNEMPLOYED, N (%) 39 (21.7) 
RETIRED, N (%) 25 (13.9) 
MARRIED, N (%) 74 (50.0) 
AGE AT ONSET, YEARS 15.9 ± 11.3 
DURATION OF EPILEPSY, YEARS 22.7 ± 13.0 
TEMPORAL EPILEPTOGENIC ZONE, N (%) 168 (86.6) 
• MESIAL, N (%) 106 (65) 
• NEOCORTICAL, N (%) 57 (35) 
EXTRATEMPORAL EPILEPTOGENIC ZONE, N (%) 26 (13.4) 
• FRONTAL EPILEPTOGENIC ZONE, N (%) 13 (6.7) 
• MULTILOBAR EPILEPTOGENIC ZONE, N (%) 10 (5.2) 
• OCCIPITAL EPILEPTOGENIC ZONE, N (%) 2 (1.0) 
• PARIETAL EPILEPTOGENIC ZONE, N (%) 1 (0.5) 
LATERALITY OF THE EPILEPTOGENIC FOCUS  
• LEFT 97 (50.8) 
• RIGHT 84 (44.0) 
• BILATERAL 10 (5.2) 
NUMBER OF ANTIEPILEPTIC DRUGS 2.3 (0.6) 
 
3.2  Psychiatric Disorders and Personality Patterns 
At the pre-surgical evaluation, 33 patients had a current psychiatric diagnosis. Thirty had 
Major Depression, 1 had a Generalized Anxiety Disorder and another had an Obsessive-
Compulsive Disorder. 
One hundred patients (70%) had a score above the threshold of 85 in at least one personality 
pattern, in the pre-surgical evaluation. Regarding their types, most patients (34%) scored 
above the defined cut-off on more than one pattern.  Twenty-three patients scored above the 
cut-off in 2 types of personality patterns and 26 patients on 3 or more. Most commonly, these 
patterns corresponded to a mixture of personality types from Cluster C (35%). The second 
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most frequent pattern was the Obsessive-Compulsive (15%) followed by the dependent 
personality pattern (9%). 
 
3.3 Predictors of dysfunctional personality patterns before surgery 
Temporal epileptogenic zone was a significant predictor of higher scores of the Avoidant 
(Coef. 11.8; CI -0.59 23.7; p=0.051) and Compulsive (Coef. 9.55; CI 2.48 16.6; p=0.008) 
personality patterns and lower scores of Histrionic (Coef. -11.4; CI -21.2 -1.55; p=0.024) 
and Antisocial (Coef. -8.4; CI -15.6 -1.25; p=0.022) personality patterns. 
The side of the epileptogenic zone was not found to be a significant predictor of personality. 
Within people with a temporal epileptogenic zone, mesial and non-mesial locations were 
also not significantly associated with personality patterns. 
 
3.4 Longitudinal changes in the proportion of patients with pathological personality 
patterns 
After surgery, the percentage of people scoring above 85 dropped to 58%. The difference 
was marginally significant (OR 4.5; CI 0.93-42.8; p=0.065) in the first analysis. The 
personality patterns with the most significant score reductions were Histrionic, Narcissistic, 
Antisocial, Aggressive and Passive-Aggressive. 
The multivariate generalized estimating equation model including all considered variables 
showed a statistically significant reduction in the proportion of patients with a dysfunctional 
personality pattern (Coef. -1.83; CI -3.26 -0.39; p=0.013) across time. None of the variables 
included were significantly associated with this decrease.  
Medium scores and standard deviation of each personality pattern, before and after surgery, 
were summarized in Table 5.  
Table 5 - Clinical personality patterns according to MCMI-II. 
 BEFORE SURGERY ONE YEAR 
AFTER SURGERY 
SCHIZOID 63.2 ± 20.3 67.7 ± 21.5 
AVOIDANT 65.4 ± 25.7 69.9 ± 25.8 
DEPENDENT 69.8 ± 24.8 69.9 ± 21.9 
HISTRIONIC 61.2 ± 21.3 54.8 ± 23.2 
NARCISSISTIC 65.0 ± 20.4 56.2 ± 26.9 
ANTISOCIAL 62.4 ± 15.5 56.1 ± 17.0 
AGGRESSIVE 62.6 ± 20.9 56.2 ± 22.0 
COMPULSIVE 75.2 ± 15.3 77.3 ± 11.8 
PASSIVE-AGGRESSIVE 55.5 ± 31.2 47.4 ± 30.8 
SELF-DEFEATING 62.3 ± 25.5 63.6 ± 27.9 
SCHIZOTYPAL 61.2 ± 17.8 60.9 ± 21.2 
BORDERLINE 55.3 ± 20.7 54.3 ± 21.3 
PARANOID 65.7 ± 16.1 64.5 ± 11.5 
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A graphical representation of the rate of dysfunctional personality patterns, before and after 
surgery, was illustrated in Figure 1. 
Figure 1 - Dysfunctional personality rates before and one-year after surgery. 
 
 
Medium scores and standard deviation of HARS and HDRS, before and after surgery, were 
summarized in Table 6.  
Table 6 - HDRS and HARS total scale medium scores. 
 Before surgery One year after 
surgery 
HDRS 8.35 ± 7.8 6.36 ± 6.4 
HARS 8.74 ± 7.0 7.06 ± 7.2 
 
4 Discussion 
In our sample, 70% of people with medically refractory epilepsy displayed a dysfunctional 
personality pattern before surgery. The most common types were Cluster C personality 
patterns, which is in line with previous studies[114–116].  
One year after surgery, there was a statistically significant reduction in the rate of 
dysfunctional traits, although of small magnitude. We hypothesize that the removal of the 
epileptogenic zone or/and the reduction of the interictal epileptic activity might have had a 
beneficial role.  There are very few studies regarding the impact of epilepsy surgery on 
personality disorders and traits. Previous data using the Minnesota Multiphasic Personality 
Inventory suggested a decrease in some dysfunctional personality traits, namely, 
interpersonal sensitivity, irritability, social introversion, hypochondriasis, and 
psychasthenia, after TLE surgery[120,121]. 
Additionally, this study showed different personality patterns in people with refractory 
epilepsy. Those with temporal epileptogenic zones had higher scores in DSM cluster C 



































patterns – Histrionic and Antisocial. Since the comparison was made between temporal and 
extratemporal patients, this implies that those with extratemporal epileptogenic zones 
(mostly frontal lobe epilepsies) had higher scores on these cluster B patterns and lower 
scores on the cluster C patterns. 
There is a scarcity of studies focusing on the determination of the neurobiological basis of 
personality disorders, in people with and without epilepsy. The studies available suggest a 
link between cluster B personality disorders and frontal lobe dysfunction, while cluster C 
personality disorders may have an association with temporal lobe dysfunction. In particular, 
the personality characteristics of “interictal personality” have been associated with mesial 
epileptogenic zones[5]. More recently, introversion related behaviors and anxiety, that may 
be seen in cluster C personality disorders, have also been associated with mesial temporal 
pathology[122]. In our work, no differences were detected between patients with mesial 
versus neocortical temporal epileptogenic zones. This may be due to potential limbic 
dysfunction even in neocortical epilepsies, to the importance of other temporal zones for 
social cognition and interaction[123] or to the inability of the test to detect these differences.  
Helmstaedter (2001) stated that people with TLE tend to manifest more anxiety, neuroticism, 
and social limitations while those with frontal epilepsy show executive dysfunctions, 
hyperactivity and addictive behaviors[124].  
Despite the controversy, some of the classical personality characteristics attributed to people 
with TLE resemble those found in cluster C personality disorders, namely, hypermoralism, 
dependency, humorlessness, obsessionalism, viscosity and circumstantiality[6]. On the other 
hand, people with Juvenile Myoclonic Epilepsy, linked to frontal dysfunction, seem to have 
more frequent cluster B traits such as impulsive and irresponsible behavior[125]. In a 
previous study, reversible interictal antisocial behavior was reported in 4 persons with 
epilepsy involving the prefrontal cortex. All of these patients fulfilled the DSM-IV criteria 
for Antisocial Personality disorder and these characteristics remitted following seizure 
control[126]. 
Moreover, Pizzi et al. (2009), using the Personality Assessment Inventory, reported a similar 
pattern. In their sample, people with frontal lobe epilepsy had more borderline and antisocial 
interictal traits than those with a temporal lobe epileptogenic zone[127]. These dysfunctional 
traits may be related to social cognition deficits, as impaired humor appreciation and 
decreased ability to detect facial expression[128,129].  
A recent study evaluated a patient with crossed obsessive-compulsive personality disorder 
and impaired theory of mind in temporal lobe epilepsy. The authors found that this patient 
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revealed impaired interpretation of other people's behavior, mental rigidity, and a tendency 
to formulate inflexible judgments[130]. 
The neuroanatomical mechanisms that may contribute to the development of personality 
disorders have also been investigated in non-epileptic patients. Both the orbital prefrontal 
cortex (OFC) and the anterior cingulate gyrus (ACG) display important roles in social 
judgment, control of aggression and other non-sanctioned behavior. Cluster B patients tend 
to have impairments in these abilities. Disinhibited angry behaviors have been shown both 
in patients with personality disorders, such as Borderline or Narcissistic and in patients with 
damage to the prefrontal cortex. This brain area seems to act by inhibiting the amygdala 
activation, and therefore, inhibiting impulsive aggression[131]. Histrionic personality 
disorders have been frequently associated with conversion disorders, in particular, 
psychogenic non-epileptic seizure (PNES)[132]. These disorders also seem to be associated 
with prefrontal cortex hypoactivation[133]. Raine et al. (2000) showed that prefrontal 
structural deficit, related to a significant reduction in prefrontal gray but not white matter, 
may underlie the low arousal, poor fear conditioning, lack of conscience, and decision-
making deficits that have been found to characterize cluster B personality patterns[134]. 
Despite the fact that the neurobiology of Cluster C personality disorders remains mostly 
unexplored, enlarged striatal and OFC/prefrontal volumes have been shown in patients with 
obsessive-compulsive traits[106]. We hypothesize that, contrary to cluster B patients, they 
may have a hypoactivation of the limbic system, both because of excessive inhibition from 
these cortical areas or dysfunction of important limbic structures such as the amygdala and 
hippocampus seen in temporal lobe epilepsy. 
This study has some limitations. Firstly, this was an observational study, with a retrospective 
component, and therefore subject to bias. Different sources of information were considered 
in order to confirm clinical information and to reduce missing data. Secondly, the MCMI-II 
corresponds to DSM-III which was the most recent version of this questionnaire when the 
first surgical candidates were assessed and we decided to keep it in order to maintain a 
homogeneous method of personality evaluation. Most of the personality categories and 
Millon’s conception of personality patterns have prevailed until the publication of DSM-5. 
Despite the fact that MCMI is an important and widely used instrument to evaluate 
personality, it has never been used in epilepsy, so we cannot compare our results with other 
studies. Moreover, we also did not apply the NBI and investigated the characteristics of the 
“interictal personality” syndrome that could be interesting to compare with our MCMI 
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results. Thirdly, the type of antiepileptic drugs was not controlled and these may have an 
impact on mood and behavior.  
Despite these constraints, our study showed some important data regarding personality 
patterns in people with refractory epilepsy, using a tool designed to evaluate personality 
prototypes from a standard diagnostic classification system. We showed that most of these 
patients have a Cluster C Personality Disorder pattern, although different epileptogenic 
zones may contribute to different dysfunctional personality patterns. Epilepsy surgery may 
also have a potentially beneficial role on the course of these dysfunctional patterns. 
These results may contribute to a better understanding of dysfunctional personality in 
epilepsy and how epilepsy-related factors may contribute to distinctive dysfunctional 
patterns. The recognition of the most common personality disorders in epilepsy could 
improve the management of these patients in the setting of multidisciplinary care.  This work 
may also contribute to the elucidation of the neurobiological basis of personality disorders.  
Future studies, with more robust samples, are encouraged to deepen the knowledge of the 
relationship between epilepsy and personality disorders as well as the potential role of 
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Objective  The aim of this study is to determine potential risk factors for de novo 
psychiatric syndromes after epilepsy surgery. 
Methods  Refractory epilepsy surgery candidates were recruited from our Refractory 
Epilepsy Reference Centre. Psychiatric evaluations were made before surgery 
and every year, during a 3-years follow-up period. Demographic, psychiatric 
and neurological data were recorded. The types of surgeries considered were 
resective surgery (resection of the epileptogenic zone) and palliative surgery 
(deep brain stimulation of the anterior nuclei of the thalamus (ANT-DBS)). 
A survival analysis model was used to determine pre and post-surgical 
predictors of de novo psychiatric events after surgery.  
Results  One hundred and six people with refractory epilepsy submitted to epilepsy 
surgery were included. Sixteen people (15%) developed psychiatric disorders 
that were never identified before surgery. Multilobar epileptogenic zone 
(p=0.001) and DBS of the anterior nucleus of the thalamus (p=0.003) were 
found to be significant predictors of these events. 
Conclusion  People with more generalized epileptogenic activity and those who are 
submitted to ANT-DBS seem to present an increased susceptibility for the 
development of mental disorders, after neurosurgical interventions, for the 
treatment of refractory epilepsy. People considered to be at higher risk should 
be submitted to more frequent routine psychiatric assessments.   




More than 50 million people around the world have epilepsy[135], a debilitating 
neurological disorder associated with several comorbidities, particularly, psychiatric 
conditions[136]. Indeed, it is estimated that up to 60% of this population suffer some 
psychiatric disorder and the risk of death from suicide may be 5.8 times higher than in the 
general population[137,138].  
About one-third of people with epilepsy do not respond to adequate antiepileptic drug 
treatment[47], they are considered to have refractory epilepsy and may be candidates for 
epilepsy surgery. Resective surgery is the most common procedure for those who have a 
well localized epileptogenic zone, and about 70% of those submitted to this procedure 
became seizure free[43]. The most common type of localized epileptogenic zone affects the 
temporal lobe, particularly, mesial structures. A smaller proportion affects neocortical 
zones[36,37].  
Those who are not candidates for resective surgery, generally, because of multiple 
epileptogenic zones or lack of an identifiable epileptogenic zone, may undergo palliative 
surgery, such as, neuromodulation interventions. Vagus Nerve Stimulation (VNS), or more 
recently, Cortical Responsive Stimulation (CRS) or Deep Brain Stimulation (DBS), 
targeting the anterior nucleus of the thalamus (ANT), bilaterally, are currently the most 
frequently employed techniques  
Despite the high rates of success of resective surgery in the control of epileptic seizures, 
about 20% of people with refractory epilepsy may develop de novo psychopathology after 
surgery[56], most commonly, adjustment disorders and depression[139].  
Few studies have focused on predictors of de novo adverse psychiatric events after resective 
surgery, such as major depression, mania, and psychosis. Some have found that receiving 
psychiatric treatment or a history of mental illness, namely, depression or anxiety, before 
surgery, was a risk factor for psychopathology after resective surgery[140,141]. However, 
this association may only reflect the natural history of previous disorders. Other potential 
risk factors include higher prevalence of mood disorder among first- and second-degree 
relatives[142], preoperative bilateral electroencephalogram (EEG) abnormalities[143], 
preoperative history of secondary generalized tonic-clonic seizures[144], persistence of 




Concerning ATN stimulation, the most common modality of DBS (ANT-DBS), some 
studies suggest that it might have a positive impact on mood[147,148], while others found 
worse depression scores after this procedure[149,150].  
Establishing potential risk factors for de novo psychopathology would allow clinicians to 
inform people with refractory epilepsy better before surgery and to be more attentive to those 
presenting these factors. 
We aim to study the potential risk factors for de novo psychopathology following epilepsy 
surgery, either resective surgery or Deep Brain Stimulation of the anterior thalamus nucleus 
DBS-ATN.  
 
2. Methods  
This ambispective cohort study was conducted at the Neurosciences` Department, that 
includes the Psychiatric, the Neurological and Neurosurgical Departments, of Hospital de 
Santa Maria (Lisbon), between May 2004 and May 2018. Subjects were recruited from the 
Refractory Epilepsy Reference Centre and the Epilepsy Surgery Group of our institution. 
The considered total follow-up period was 36 months, after surgery, although not all subjects 
were followed during this entire period because of loss of follow-up. Patients were evaluated 
by the psychiatrist belonging to both the center and group before surgery and after 12, 24 
and 36 months. Follow-up time was measured in months. The diagnosis of refractory 
epilepsy was made according to the International League Against Epilepsy[39]. 
Presurgical surgery evaluation, in our group, includes, at least, a video-EEG monitoring, a 
3-Tesla brain magnetic resonance with epilepsy protocol, and neuropsychological and 
psychiatric evaluation. Our reference center includes patients with temporal and extra-
temporal epileptogenic zones. The location of the epileptogenic zone is determined using 
surface preoperative magnetic resonance imaging (MRI), functional magnetic resonance 
imaging (fMRI) and positron emission tomography scans and video–
electroencephalography (EEG). In our institution, the majority of people with refractory 
epilepsy who underwent surgery are submitted to resective surgery, a smaller proportion of 
VNS or ANT-DBS. People submitted to VNS will not be included in this study given the 
lack of enough follow-up data. 
Data concerning demographic (gender, age, employment status, marital status, etiology of 
epilepsy, the topography of the epileptogenic zone, the age of onset, time to surgery), and 
Engel Class[151] after surgery were collected during interviews and from medical and 
surgical records. In the pre-surgical period, patients were under, at least, two antiepileptic 
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drugs, but their type and dosages were not addressed in this study because there was 
considerable variability between patients as it is usually in people with refractory epilepsy. 
However, in our center patients keep the same antiepileptic drugs and therapeutic schemes 
for at least 2 years after surgery. 
During follow-up, patients were seen regularly by the members of the Epilepsy Surgery 
Group and referred to psychiatry if they develop de novo psychopathology after surgery. 
Information concerning the referral to psychiatry was also registered.  
This study has been performed in accordance with the ethical standards of the 1964 
Declaration of Helsinki and its later amendments and was approved by the Ethics Committee 




Participants older than 18 years, submitted to resective surgery or DBS were included in the 
study. Patients with other neurological diseases or intellectual disability were excluded from 
the analysis. One hundred and eighty-one consecutive people with refractory epilepsy who 
were proposed to pre-surgical evaluation were enrolled. Fifteen were secondarily excluded 
because of intellectual disability (QI<70), 13 because they did not undergo surgery, 44 
because of loss of follow-up, 1 because he has undergone VNS; finally, 1 died and 1 refused 
to participate. Thus, a total of 106 individuals were included in the study.  
 
2.2 Psychiatric evaluation 
Psychiatric evaluations include a clinical psychiatric history (demographic data, previous 
psychiatric history, psychiatric medication, family history, use of substances as well as other 
relevant clinical data).  The evaluation also included the following psychopathological tests: 
 
2.2.1. The Hamilton Anxiety Rating Scale (HARS) 
This rating scale was developed to measure the severity of anxiety symptoms consisting of 
14 items and measures both phobic anxiety and somatic anxiety[57]. 
 
2.2.2. The Hamilton Depression Rating Scale (HDRS) 
This is the most widely used rating scale used to access depression. The version used 
corresponds to the original 17 items version and has a particular focus on melancholic and 
physical symptoms[58].  
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2.2.3. Brief Psychiatric Rating Scale (BPRS) 
This rating scale is one of the most widely used scales to measure psychotic symptoms and 
it is based on the interview with the patient, his speech and behavior.  
 
2.2.4. Symptom Checklist-90 (SCL-90) 
This multi-dimensional instrument is a is a 90-item self-report symptom inventory 
developed to measure psychological symptoms and psychological distress. There are three 
global indices for the SCL-90: the Global Severity Index (GSI), the Positive Symptom 
Distress Index and the Positive Symptoms Total. The GSI is suggested to be the best single 
indicator of the current level of the disorder.  
After this initial evaluation, people with refractory epilepsy presenting major psychiatric 
disorder or considered to have a higher risk of developing psychiatric disorder were referred 
to a psychiatric outpatient clinic of one of the investigators.   
De novo major psychiatric disorders were classified according to the International Statistical 
Classification of Diseases and Related Health Problems (ICD-10)[117]. Lifetime prevalence 
of psychiatric syndromes was determined using information from patients and family 
members, accompanying the patient, at the pre-surgical evaluation moment. 
 
2.3 Statistical analysis  
The statistical analysis was performed using Stata software (version 14.2; StataCorp, Texas, 
USA). Descriptive statistics were used to report the analysis of data presented as mean ± 
standard deviation or number and proportions. Student's t-test and the Mann-Whitney U test 
were used for parametric and non-parametric data, respectively. As the population studied 
is an open cohort, person-time variables were taken into account in a time-to-event analysis. 
Potential risk factors were analyzed using the Cox Proportional Hazards Model.  
First, we performed univariate analysis including variables that were considered to have 
clinical relevance both for epilepsy and psychiatric disorders. These variables include sex, 
age at surgery, years of education, duration of epilepsy and age at onset of epilepsy, analyzed 
as continuous variables. Employment and marital status, epileptogenic zone side (right, left 
or bilateral cerebral hemispheres), epileptogenic zone topography (temporal, extratemporal 
or multilobar), as categorical variables. As Engel Classes (I, II, III, or IV) reflect progressive 
stages of prognosis with Class I meaning “Seizure free or no more than a few early, 
nondisabling seizures; or seizures upon drug withdrawal only” and IV reflecting “No 
worthwhile improvement; some reduction, no reduction, or worsening are possible”[151] 
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we treated these variable as continuous in order to increase the power of our analysis. 
Previous history of other mental disorders, family history of psychiatric disorders, 
epileptogenic zone concerning one (unilobar) versus more than one lobe (multilobar) and 
resective surgery vs ANT-DBS, analyzed as binary variables.  
The outcome variable, de novo psychopathology, was coded as a binary variable (0=no 
event; 1=at least one event). 
Variables achieving statistical significance as predictors of de novo psychopathology were 
included in a multivariate analysis. 
The assessment of model assumptions was tested using Schoenfeld residuals test.  
Measures of association were expressed as hazard ratios. A significant P value from the Cox 
Proportional Hazards Model was set at ≤0.004, after a Bonferroni correction was made, 
considering the number of tests performed (14).  
Ties were handled using the Efron method for ties.  
 
3. Results 
3.1 Demographic and clinical findings of the people with refractory epilepsy with 
and without de novo psychopathology 
The study included 106 persons with refractory epilepsy. Ninety-two (88%) had a temporal 
epileptogenic zone, 57 (62%) had mesial sclerosis and 34 (37%) other pathologies, 1 had a 
parietal epileptogenic zone, 7 a frontal epileptogenic zone and 5 had an epileptogenic zone 
affecting more than one brain lobe (Table 7). 
After surgery, the majority of people were considered to be Class Engel I (75%). No 
statistically significant differences were found, concerning these variables, between patients 
with and without follow-up. 
Regarding lifetime psychiatric history, no statistical differences were found between patients 
submitted to resective surgery or ANT-DBS. In the first group, 62 patients had no previous 
psychiatric history, 36 had a history of depression, 6 had a history of an anxiety disorder, 3 
had a history of a psychotic disorder, 6 had a history of alcohol or drug abuse and the rest of 
the sample had other pathologies. In the second group, 3 had no previous diagnosis and 4 
had a lifetime history of depression. At the pre-surgical evaluation, patients had a medium 
HARS score of 8,6±6,9, a medium HDRS score of 8,3±7,7, a medium BPRS of 27,4±8,9 
and the medium score of the GSI of SCL-90 was 0,9±0,6. No statistical differences were 




Table 7 - Clinical characteristics and socio-demographical of the participants. 
 Clinical and socio-demographical characteristics  
Mean±SD Range 
Age, years 37.6 ±10.7 18 - 65 
Sex/Males, n (%) 40 (37.7)  
Education, years 10.2 ±4.4 1 - 18 
Active workers, n (%) 57 (58.8)  
Married, n (%) 49 (49)  
Age at onset, years 14.4±10.1 1 - 58 
Duration of epilepsy, years 23.2 ±12.9 3 - 59 
Temporal epileptogenic zone, n (%) 92 (87.6)  
Extratemporal epileptogenic zone, n (%) 8 (7.6)  
Multilobar epileptogenic zone, n (%) 5 (4.8)  
The side of the epileptogenic focus   
• Left 50 (47.2)  
• Right 52 (49.1)  
• Bilateral 4 (3.8)  
Number of antiepileptic drugs 2.3±0.6 1 - 4 
Type of surgery, n (%)   
• Resective surgery 99 (93.4)  
• Deep brain stimulation 7 (6.6)  
 
3.2 De novo major psychopathology 
After surgery, 16 patients (15%) developed a major psychiatric syndrome that has never 
been reported before surgery. The incidence rate was 0,005 events per month. The mean 
time until the first psychiatric event was 13 months and the median was 7 months (ranging 
from 1 to 36 months). Nine had a de novo depressive episode (F32) (8% of the sample), 6 
had an acute and transient psychotic disorder (F23) (6%), 2 had a manic episode (F30) (2%) 
and 1 patient had a de novo anxiety disorder (F41) (1%). Four patients had 2 events during 
the follow-up period. Treatment and psychiatric follow-up were offered to all these patients 
and all improved with treatment.  
 
3.3. Results from the Cox Regression Model 
Multilobar epileptogenic zone, bilateral epileptogenic zone, ANT-DBS and higher Engel 
Class were found to be significant predictors of de novo major psychopathology, after 
surgery, with hazard ratios of 13.24 (CI 95% 4.22-41.49; p<0,001), 7.68 (CI 95% 1.90-
31.01; p=0,004), 7.84 (CI 95% 2.58-25.22; p<0,001) and 2.18 (CI 95% 1.36-3.49; p=0,001), 
respectively.   
On the multivariate model, laterality and Engel Class after surgery were not significant 
predictors. Using backward selection, only variables concerning unilobar versus multilobar 
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epileptogenic zone and type of surgery were included in the final model with hazard ratios 
of 9 (CI 95% 2.60-31.19; p=0,001) and 6.81 (CI 95% 1.95-23.78; p=0,003), respectively.  
Schoenfeld residuals test showed no statistically significant results allowing us to assume 
that there is no departure from the proportional hazards assumption.  
Multicollinearity was not detected using the Variance Inflation Factor test. 
Kaplan-Meier curves showed a much shorter time to event for patients with multilobar 
compared to unilobar epileptogenic zone (Figure 2) and for those submitted to ANT-DBS 
comparing to resective surgery (Figure 3).  
 
Figure 2 - Kaplan-Meier estimates of survival comparing multilobar to unilobar epileptogenic zone 
(p<0.001). 
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This cohort study was conducted in a reference center for refractory epilepsy using a sample 
of people who underwent surgery. Our aim was to identify clinically relevant risk factors for 
the development of major psychopathology that was not identified, in these patients` life, 
before surgery. 
Forty-two percent of the surgical candidates, of this sample, had a lifetime history of at least 
one psychiatric disorder. This high prevalence is in line with other studies using a sample of 
refractory epilepsy patients[152,153].  
After the surgical procedure, although the overall quality of life and psychiatric 
symptomatology improvement have been reported, for the majority of people with refractory 
epilepsy[154], a significant proportion of patients may develop serious psychiatric 
episodes[141]. In our sample, 15% of participants developed major psychiatric episodes that 
were never reported before surgery. However, these events were transient and responded to 
pharmacotherapeutic intervention. This incidence rate is higher than what would be expected 
in the general population in the same 3-year period[155,156] and appear to be surgery related 
as half of the patients with de novo psychopathology had the first event up to 7 months after 
surgery.  
The main predictors of major psychiatric events were an epileptogenic zone affecting more 
than one lobe and being submitted to ANT-DBS. People with multilobar epileptogenic zone 
were 9 times more likely to develop new psychiatric events after surgery, and those 
submitted to DBS were almost 7 times more likely to develop these events.  
A multilobar epileptogenic zone reflects a more widespread brain epileptogenicity. This 
finding is in line with previous studies, showing an association between a more general 
attainment of the brain such as bilateral functional and structural abnormalities, bilateral 
interictal discharges and frontal hypometabolism after temporal lobe surgery and the 
emergence of new psychopathology after surgery[143,157,158]. 
Generalized epileptiform activity may disrupt important circuits involved in the control of 
mood and behavior, leaving patients more vulnerable to develop these disorders after a major 
neurosurgical procedure. 
The second significant predictor was the type of intervention. Patients submitted to ANT-
DBS have a higher hazard of developing psychiatric disorders after surgery. In previous 
literature, the stimulation of the ANT, in refractory epilepsy, has been associated with higher 
rates of self-reported depression[159]. A more recent study, with 22 patients submitted to 
ANT-DBS, for the treatment of refractory epilepsy, showed that 2 patients, with a history of 
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depression, developed depressive symptoms and 2 others, with no history of psychosis, 
developed clear paranoid symptoms and anxiety[160].  
Earlier studies concerning DBS use on Parkinson Disease and dystonia have found an 
association between this procedure and other serious psychiatric events such as 
hypomania/mania[161], psychotic disorders[162] and suicidal ideation/attempts[163]. There 
seems to be a different risk of developing mania or depression according to the location of 
the electrodes[164,165]. Older patients might also be particularly vulnerable to adverse 
psychiatric events[166].  
Patients with refractory epilepsy submitted to this type of surgery may, likewise, be at a 
higher risk of the same psychiatric adverse events. This can be explained by the fact that 
although there are different targets, according to the disease that is intended to be treated, 
these structures participate in circuits that have implications for the control of mood and 
cognition. 
This study has some limitations. It was an observational ambispective study with a 
retrospective component. There are some missing data and loss of follow-up. To account for 
this limitation, we used a survival analysis model. Secondly, as only annual evaluations were 
carried on, inter-evaluation disturbances may have been missed. Notwithstanding, 
psychiatrists involved were in constant communication with other members of the Epilepsy 
Surgery Group involved in the follow up of participants, and, every time a psychiatric 
disturbance was identified, they were promptly referred to a psychiatric consultation. We 
did not control for the type of antiepileptic drugs or changes in dosages. Some antiepileptics 
may have different effects on mood and behavior, however, as previously stated, for the 
majority of patients no changes were made during the follow-up period. Moreover, we didn´t 
analyze each type of psychiatric episode separately. Although they have different clinical 
presentations, only major episodes and serious adverse psychiatric events were considered. 
The occurrence of any of these events is always an important factor that has a major impact 
on quality of life of people with epilepsy. 
Another important limitation is related to the possibility that, during pre-surgical evaluation, 
patients and families underreport psychiatric symptoms because they may be considered it a 
“natural reaction” to epilepsy or because of their fear of not being qualified for surgery. This 
may lead to an overestimation of what could be considered de novo psychopathology. 
Furthermore, as the sample size is relatively small, there are only a few numbers of events 
limiting the statistical power and stability of our models.  
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Despite these constraints, our study allows the identification of clinical variables that could 
be associated with an increased risk for de novo psychiatric events and a shorter time-to-
event, after surgery. Moreover, it may suggest potential biological mechanisms involved in 
post-surgery psychiatric morbidity. New studies with larger number of patients submitted to 
DBS and resective surgery for epilepsy are required to confirm these results. Our study also 
reinforces the need for a comprehensive assessment of patients, the importance of adequate 
counseling pre-surgery and psychiatric follow-up. We suggest that patients with a multilobar 
epileptogenic zone and those submitted to invasive procedures for the treatment of epilepsy-
like refractory epilepsy, particularly, DBS, should be submitted to more frequent psychiatric 
routine assessments after surgery. 
In conclusion, our study identified two important factors that are highly associated with an 
increased risk of developing a serious psychiatric event after surgery, a wider epileptogenic 
zone and thus a more general involvement of different areas and brain circuits and the 
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Objectives  People with refractory epilepsy submitted to surgery may improve or 
deteriorate their cognitive and emotional function. The aim of this study is to 
determine the predictors of longitudinal changes in psychopathological 
symptomatology, one year after epilepsy surgery, considering clinical and 
demographic characteristics. 
Methods  People with refractory epilepsy referred to epilepsy surgery were included in 
this ambispective study. Psychiatric evaluations were made before surgery 
and one year after the procedure. Demographic, psychiatric and neurological 
data were recorded. Linear regression was used to analyze longitudinal data 
regarding the Global Severity Index and 9 symptom dimensions of Symptom 
Checklist-90 (SCL-90). 
Results  Seventy-six people were included. Bilateral epileptogenic zone, lack of 
remission of disabling seizures and Deep Brain Stimulation, targeting the 
anterior nucleus of the thalamus (ANT-DBS), were the most important 
predictors of an increase in SCL-90 scores, after surgery. 
Conclusion  Some individual factors may have an impact on the development or 
worsening of the previous psychopathology. This study identifies clinical 
aspects associated with greater psychological distress, after surgery. These 
patients may benefit from more frequent psychiatric routine assessments for 
early detection.  
 




About one-third of people with epilepsy do not respond to adequate antiepileptic drug 
treatment[47]. These people are considered to have refractory epilepsy, a chronic and 
debilitating condition with a great impact on patients’ quality of life[167,168]. 
Not surprisingly, previous studies have reported high rates of mental disorders and 
psychopathological symptoms in people with epilepsy, particularly in those suffering from 
refractory epilepsy[136,168,169]. The most commonly reported disorders are affective and 
anxiety syndromes[36,37].  
Most people with refractory epilepsy display a well-characterized lesion considered to be 
the epileptogenic zone. Focal epilepsy affects, most frequently, the temporal lobe, 
particularly mesial structures – the hippocampus and the amygdala[36,37]. These people 
may be eligible for resective surgery, a procedure that is effective in the remission of seizures 
of about 70% of the cases[43]. For those whom, by any reason, surgical resection is not 
feasible, other options may be considered, namely, neuromodulation interventions, such as 
Vagus Nerve Stimulation (VNS) or Deep Brain Stimulation, targeting the Anterior Nucleus 
of the Thalamus (ANT-DBS)[47]. 
Epilepsy surgery improves quality of life, even in those who are not seizure-free[170] plus 
may have a positive impact on the severity of depression, anxiety and total psychiatric 
symptoms[171–173].  
Previous studies, focusing on psychopathological dimensions after epilepsy surgery, have 
reported that psychiatric symptoms tend to decrease over time[171,174]. Although most 
patients seem to achieve a general improvement, others develop de novo psychopathology 
or may worsen their previous psychiatric condition[175]. In fact, epilepsy surgery has been 
associated with a high risk of mortality secondary to suicide[176]. Death from suicide occurs 
even after successful surgery in which people who became seizure free[177]. 
Meldolesi et al. have shown a decrease of some state and trait emotional variables, as well 
as personality variables, such as interpersonal sensitivity, irritability, social introversion, and 
paranoia, at 1-year and 2-year follow-up evaluations, after surgery[174]. Similarly, Payson 
et al. reported improvement in some subscales of the Personality Assessment Inventory that 
differed according to the surgical side and location, highlighting the importance of 
considering psychological changes according to patient´s clinical characteristics[178]. 
Regarding ATN-DBS, some studies suggest that it might have a positive impact on 
mood[147,148], while others found that it could worse depression scores[149,150]. The 
anterior nucleus of the thalamus has a critical position in the “Papez circuit”, a group of brain 
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regions with an important role on emotional and cognitive control. ATN-DBS may disrupt 
this circuit. It has been demonstrated that this procedure has deleterious effects on cognitive 
control and emotion-attention interaction[179]. Consequently, it may lead to dysfunctional 
mood and cognitive regulation, as well as, to an increased risk of psychopathological 
symptoms and psychiatric disorders. 
While epilepsy surgery seems to have an impact on the psychopathological outcome, some 
authors suggested that presurgical psychopathology could also have an impact on the 
neurological outcome[76] suggesting a bidirectional relationship between these entities. 
However, a recent large cohort study by Altalib et al. (2018) did not confirm this 
association[180].  
Despite the growing interest in psychopathology, both before and after surgery, there is a 
paucity of studies concerning the influence of different clinical features and surgical 
procedures on the post-surgical psychopathological symptoms of people with epilepsy. The 
purpose of this study was to address this issue. 
 
2. Methods  
This ambispective observational study was conducted at the Neurosciences` Department, of 
our institution, between February 2008 and October 2018. Retrospective and prospective 
data collection started after the study´s approval by our local Ethics committee in 2015. 
Subjects were recruited consecutively from the Refractory Epilepsy Reference Centre and 
the Epilepsy Surgery Group. The follow-up period was 12 months after surgery. Participants 
were evaluated by the psychiatrist belonging to both the Center and Group. The diagnosis of 
refractory epilepsy was made according to the definition of the International League Against 
Epilepsy[39]. 
Presurgical surgery evaluation, in our Group, includes, at least, a video-EEG monitoring, a 
3-Tesla brain magnetic resonance with an epilepsy protocol, and a neuropsychological and 
psychiatric evaluation. Most patients are submitted to resective surgery, a smaller proportion 
of them undergo ANT-DBS or VNS. Only patients submitted to resective surgery or DBS 
were enrolled in this study because of a lack of detailed follow-up data of patients submitted 
to VNS.  
Demographic (gender, age, employment status, marital status) and clinical data (etiology of 
epilepsy, the topography of the epileptogenic zone, the age of onset, time to surgery and 
Engel Class[151]), registered one month after surgery, were collected during interviews and 
from medical and surgical records. In the pre-surgical period, people were under, at least, 
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two antiepileptic drugs, but their type and dosages were not addressed in this study because 
there was considerable variability between people, as it usually is in this population. 
However, in our center, people keep the same antiepileptic drugs and therapeutic schemes 
for at least 2 years after surgery. 
A written consent form was obtained from participants evaluated prospectively and the study 
was approved by the local Ethics Committee.  
 
2.1 Subjects 
Participants older than 18, submitted to resective surgery or DBS were included in this study. 
People with other neurological diseases or intellectual disability were excluded.  
 
2.2 Psychiatric Evaluation 
Psychiatric evaluations were performed, before and 12 months after surgery, by one of the 
3 psychiatrists from our group (LCP, FN, SL) and include a clinical psychiatric history 
(demographic data, previous psychiatric history, family history, use of substances as well as 
other relevant data) and Symptom Checklist-90 (SCL-90). This multi-dimensional 
instrument is a 90-item self-report symptom inventory developed to measure psychological 
symptoms and psychological distress. It has 9 subscales evaluating different symptom 
dimensions: somatization, obsessive-compulsive, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism and a global scale called 
Global Severity Index (GSI)[67]. 
 
2.3 Statistical Analysis  
The statistical analysis was performed using Stata software (version 14.2; StataCorp, Texas, 
USA). Descriptive statistics were presented as mean ± standard deviation or as the number 
of subjects/cases and proportions. 
A paired t-test was used to compare pre and post total medium GSI scores. 
For the longitudinal evaluation of SCL-90 subscales and GSI scores, after epilepsy surgery, 
as outcome variables, we performed Linear Regression. A set of predictor variables, 
clinically relevant both for epilepsy and psychiatric disorders, were included, as well as the 
SCL-90 baseline scores as a covariate.  
Predictor variables include sex, age at surgery, duration of epilepsy and age at onset of 
epilepsy, analyzed as continuous variables. Epileptogenic zone side (right, left or bilateral 
cerebral hemispheres) and epileptogenic zone topography (temporal, extratemporal or 
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multilobar), and Engel Classes (I, II, III, or IV)[151], as categorical variables. Mesial versus 
non-mesial temporal epileptogenic zone and resective surgery vs ANT-DBS, analyzed as 
binary variables.  
Normality of residuals was tested for each model.  
Measures of association were expressed as coefficients and a p-value ≤0.05 was considered 
statistically significant.   
 
3 Results  
3.1 Demographic and clinical findings 
One hundred and eight consecutive people with refractory epilepsy proposed to pre-surgical 
evaluation were enrolled. Ten were secondarily excluded because of intellectual disability 
(IQ<70), 18 because they did not undergo surgery, 2 because they underwent VNS; finally, 
1 died and 1 refused to participate. Thus, a total of 76 individuals were included in the study.  
Demographic and clinical characteristics are described in Table 8.  
Sixty-three (85%) people had a temporal, 7 a frontal and 4 an epileptogenic zone affecting 
more than one cerebral lobe, respectively. Regarding participants with temporal epilepsy, 35 
(56%) had mesial sclerosis and 28 (35%) other pathologies. 
One month after surgery, the outcomes of the majority of people (80%) were classified as 
Engel Class I. 
 
Table 8 - Demographic and Clinical characteristics of participants 
 
SOCIO-DEMOGRAPHICAL AND CLINICAL 
CHARACTERISTICS 
AGE, YEARS 39.0 ± 11.7 
MALES, N (%) 28 (36.8) 
EDUCATION, YEARS 10.6 ± 4.5 
ACTIVE WORKERS, N (%) 41 (54.7) 
UNEMPLOYED, N (%) 21 (28.0) 
RETIRED, N (%) 13 (17.3) 
MARRIED, N (%) 37 (49.3) 
SINGLE OR DIVORCED, N (%) 38 (49.3) 
AGE AT ONSET, YEARS 17.2 ± 11.8 
DURATION OF EPILEPSY, YEARS 21.7 ± 14.1 




ZONE, N (%) 
7 (9.5) 
MULTILOBAR EPILEPTOGENIC 
ZONE, N (%) 
4 (5.4) 
SIDE OF THE EPILEPTOGENIC FOCUS  
• LEFT 32 (42.7) 
• RIGHT 38 (50.7) 
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• BILATERAL 5 (6.7) 
NUMBER OF ANTIEPILEPTIC DRUGS 2.4 ± 0.6 
TYPE OF SURGERY, N (%)  
• RESECTIVE SURGERY 69 (90.8) 
• DEEP BRAIN STIMULATION 7 (9.2) 
 
 
3.2 Analysis of longitudinal changes in GSI of SCL-90 considering the total sample 
At the pre-surgical and one-year evaluation, participants had a medium GSI score of 
0.82±0.61 and 0.82±0.68, respectively. No significant differences were found considering 
the total sample.  
 
3.3 Analysis of longitudinal changes in each SCL-90 symptom dimensions scores 
considering subgroups according to clinical predictors 
Some subgroups of patients were found to have increased scores on some of the symptom 
dimensions and GSI, according to the defined predictors. 
Figures 4 to 20 represent all positive findings regarding longitudinal changes in SCL-90 
subscales and GSI. 
A summary of all positive findings has also been illustrated in Table 9. 
 
Table 9 - Summary of predictors of higher SCL-90 scores one year after surgery  
 Predictors of higher SCL-90 scores one year after surgery 
Coefficients (95% CI) 
Engel Class II 
(compared to 






Somatization 1.32 (0.73,1.90)    
Obsessive-
Compulsive 
1.62 (0.61,2.62)    
Interpersonal 
sensitivity  
0.88 (0.11,1.65)     
Depression 1.60 (0.69,2.51)    
Hostility 0.77 (0.13,1.41)  0.82 (0.05,1.59) 0.59 (0.14,1.05) 
Phobic anxiety 0.94 (0.18,1.71) Left: 0.71 (0.03,1.38) 
Right: 0.73 (0.08,1.38) 
 0.62 (0.06,1.19) 
Paranoid 
Ideation 
1.44 (0.66,2.23) Left: 1.24 (0.55,1.94) 
Right: 1.06 (0.36,1.76) 
 1.17 (0.62,1.73) 
Psychoticism 0.97 (0.22,1.73)    
Global Severity 
Index 
1.19 (0.54,1.85) Left: 0.65 (0.02,1.29) 
Right: 0.65 (0.02,1.28) 





Figure 4 - Longitudinal 
changes in GSI, according to 
the epileptogenic zone  
side. 
  
Figure 5 - Longitudinal 
changes in GSI, according to 
the Engel class. 
 
 
Figure 6 - Longitudinal 
changes in GSI, according to 




Figure 7 - Longitudinal 
changes in somatization 
subscale, according to the 
Engel class. 
 
Figure 8 - Longitudinal 
changes in the obsessive-
compulsive subscale, 
according to the Engel class. 
 
Figure 9 - Longitudinal 
changes in interpersonal 
sensitivity subscale, according 
to the Engel class. 
 
 
Figure 10 - Longitudinal 
changes in depression 
subscale, according to the 
Engel class. 
 
Figure 11 - Longitudinal 
changes in hostility subscale, 
according to the epileptogenic 
zone lobe. 
 
Figure 12 - Longitudinal 
changes in hostility subscale, 




Figure 13 - Longitudinal 
changes in hostility subscale, 




Figure 14 - Longitudinal 
changes in phobic anxiety 




Figure 15 - Longitudinal 
changes in phobic anxiety 
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Figure 16 - Longitudinal 
changes in phobic anxiety 
subscale, according to the 
epileptogenic zone side. 
 
Figure 17 - Longitudinal 
changes in paranoid ideation 
subscale, according to the 
Engel Class. 
 
Figure 18 - Longitudinal 
changes in paranoid ideation 
subscale, according to the 
epileptogenic zone side. 
 
 
Figure 19 - Longitudinal 
changes in paranoid ideation 
subscale, according to the type 
of surgery. 
 
Figure 20 - Longitudinal 
changes in psychoticism 







Considering the total sample, no significant differences were found regarding GSI, before 
and one year after surgery, although most of these patients have been free of seizures. 
However, our study showed that some clinical factors may contribute to worse GSI scores, 
reflecting a post-surgery more severe general psychopathological profile in some subgroups 
of patients: those with a bilateral epileptogenic zone, those submitted to ANT-DBS and those 
whose outcome was classified as Engel Class II.  
Having an Engel Class II compared to Engel Class I was a predictor of higher scores one 
year after surgery, affecting all SCL-90 domains, as well as the GSI. This data is in line with 
previous studies showing an association between lack of seizure control after surgery and 
increased psychopathological symptoms[158,181].  
Some hypothesis may explain this association, namely, the unmet expectations of patients 
and families. A mismatch between anticipated and real results, particularly, in those that do 
not become seizure free, may lead to family and individual distress and frustration. Patients 
with seizure recurrence may become significantly disappointed or have a sense of “failure”, 
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Continued epileptogenic activity, after a major neurosurgical procedure, may also have a 
role in the increased psychological stress of patients without seizure remission. Abnormal 
electric activity may affect, directly or indirectly, brain circuits that have important roles in 
the control of emotions and cognition[158,181]. 
After surgery, a bilateral epileptogenic zone was associated with increased phobic anxiety 
and paranoid ideation scores whereas multilobar epileptogenic zone was associated with 
higher hostility scores. 
These two characteristics could reflect more diffuse epileptogenicity, and are in accordance 
with previous findings, suggesting that a more generalized brain dysfunction could be 
associated with an increased risk for post-operative mental symptoms. Such findings also 
include a preoperative history of secondary generalized tonic-clonic seizures[144], frontal 
hypometabolism in temporal lobe epilepsy[184] and preoperative bilateral independent 
spike discharges[158]. Dysfunctionality in different brain areas and circuits probably 
constitutes an important risk factor for the emergence of psychopathological symptoms after 
a major biological stressor such as epilepsy surgery. 
Finally, the type of surgery, namely, being submitted to ANT-DBS in comparison to 
resective surgery, also contributed to the increased scores, after surgery, in the hostility, the 
phobic anxiety, and the paranoid ideation domains, as well as in the global scale. There are 
few studies reporting psychopathological outcomes after ANT-DBS for the treatment of 
refractory epilepsy. Findings include an increased risk of depression, paranoid and anxiety 
symptoms after surgery[159,160]. It is uncertain into what extent this procedure may 
contribute to the disruption of important circuits involved in mood regulation.  
A meta-analysis of psychiatric and neuropsychiatric adverse events associated with DBS, 
including different sites of stimulation, reported mixed findings regarding mood and 
behavior measured with the mentation, behavior, and mood (MBM) subscale of the unified 
Parkinson's disease rating scale. About half of the studies reported an improvement, 33% 
reported a worsening of symptoms and 11% reported no changes[185]. The fact that the 
majority of studies included in this analysis reported an improvement in psychopathological 
scores contrasts with our findings. However, this study includes many different stimulation 
sites and indications including depression and obsessive-compulsive disorder. Moreover, 
many of the studies did not report any outcomes regarding psychopathological outcomes. 
Interestingly, thalamus stimulation was associated with a higher risk of suicide, suggesting 
that this might be a particularly vulnerable structure[185]. Clearly, there is a need for further 
studies examining the psychopathological outcome after ANT-DBS. 
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This study has some limitations. The first is that this was an observational ambispective 
study with an important retrospective component. Missing information may introduce bias; 
however, different information sources were consulted to minimize the lack of data. 
Epilepsy and psychiatric pharmacological treatments were not controlled and might have an 
impact on participant psychopathological symptoms. Nonetheless, all patients with clinically 
significant mental symptoms were referred to a psychiatrist and submitted to treatment. We 
do not expect that the predictors found in our models would influence the probability of 
being treated.  
Finally, the sample size is relatively small, increasing the risk of a type II error.  
Despite these constraints, important conclusions may be drawn from our study. Our findings 
suggest that the lack of complete seizure remission, more global epileptogenicity, and ANT-
DBS are associated with more psychological distress after surgery. This research also offers 
some insights into what may constitute potential biological mechanisms involved in the 
development of psychiatric disorders and should be enhanced by prospective studies with 
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Objectives  Our aim was to determine if a history of a mental disorder predicts a worst 
neurological outcome for patients undergoing epilepsy surgery.  
Methods  We conducted an ambispective observational study including people with 
refractory epilepsy who underwent resective surgery. Demographic, 
psychiatric and neurological data were collected, before and one year after 
surgery. Pre-surgical interviews included a psychiatric evaluation and the 
determination of prevalent and lifetime psychiatric diagnosis. The one-year 
post-surgical outcome was classified according to the Engel Outcome Scale. 
Predictors of post-surgical Engel class were determined using an ordered 
logistic regression model.  
Results  A lifetime history of any mental disorder was a significant predictor of a higher 
Engel Class (p=0.017).  
Conclusion  This study shows that psychiatric lifetime diagnoses are associated with worse 
surgical outcome and highlighted the importance of the inclusion of these 
diagnoses in the evaluation of the potential success of the surgery. 
 










Psychiatric comorbidity is frequent in people with epilepsy[41,186,187]. There is an 
association between these type of disorders concerning their severity and probability of 
occurrence[188–191]. Psychiatric disorders can precede, co-occur, or follow the diagnosis 
of epilepsy[188]. Previous studies have suggested that there is a bidirectional relationship 
between mental disorders and epilepsy[192,193].  
Some aspects that may explain this association have been postulated. Psychosocial factors 
may partially explain the high prevalence of depression and anxiety in people with epilepsy. 
These factors include stigma, poor disease acceptance, and anticipatory anxiety associated 
with the unpredictable nature and outcome of seizures and the limitations imposed by the 
disease itself[194]. However, common biological factors may also explain this bidirectional 
association. Psychiatric disorders and epilepsies may share common genetic mechanisms, 
such as copy number variants, which seem to act as a non-specific risk factor for both 
epilepsy and schizophrenia, autism spectrum disorders and attention deficit hyperactivity 
disorders[26]. A hyperactive hypothalamic–pituitary–adrenal axis has been suggested as 
another putative mechanism, as an abnormal dexamethasone suppression test has been 
demonstrated in both primary major depression and in people with epilepsy without 
depression[193]. Elevated glucocorticoid levels might damage neuronal and cortical 
function, thereby increasing the synaptic glutamate levels[193]. Dysfunction of glutamate 
transporter proteins, serotonin, dopamine, and y-aminobutyric acid transporters, together 
with reduced levels of serotonin and noradrenaline, might also play a role in the pathogenesis 
of depression and epilepsy[193,195–197].  
People suffering from mental disorders and epilepsy might have a more global dysfunction 
of brain networks, neurotransmitter or neuroendocrine systems, or some other general 
mechanism. Widespread brain abnormalities have been identified in both focal epilepsy and 
some psychiatric disorders, such as schizophrenia, bipolar disorder and major 
depression[15–19].  
About one-third of people living with epilepsy do not respond to pharmacological 
treatment[38], and they are considered to have refractory epilepsy[39]. They have an even 
higher risk for psychiatric disorders[40,41].  Some of these patients may be submitted to 
surgery (resective or palliative) with different neurological outcomes. Clinical 
characteristics, such as a history of presurgical secondarily generalized convulsive seizures, 
learning disability, an extratemporal epileptogenic zone, bilateral hippocampal sclerosis and 
bi-temporal interictal epileptiform discharge, as well as palliative procedures, have been 
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shown to increase the probability of recurrence of seizures after surgery[44,76,203]. 
Inversely, higher age at onset and a shorter duration of epilepsy have been associated with a 
better post-surgery seizure control[204,205].  
Some previous studies have suggested that a lifetime history of psychiatric disorders is also 
associated with a poor post-surgical seizure outcome[76,206,207]; however other studies did 
not confirm this finding[208,209]. Hence, we believe that this important subject deserves 
further investigation. 
People suffering from mental disorders and epilepsy might have a more global dysfunction 
of brain networks, neurotransmitter or neuroendocrine systems and potentially a more 
serious disorder. Widespread brain abnormalities have been identified in both focal epilepsy 
and some psychiatric disorders, such as schizophrenia, bipolar disorder and major 
depression[198–202].  
Considering this hypothesis, the present study postulates that a pre-surgical lifetime history 
of mental disorders may be an important predictor of a worst postoperative seizure control.  
 
2 Methods  
This ambispective cohort study was conducted at the Neurosciences and Mental Health 
Department of the Hospital de Santa Maria, between April 2000 and September 2018. 
Subjects were recruited from both the Refractory Epilepsy Reference Centre and the 
Epilepsy Surgery Group. Participants were evaluated, before surgery and after 12 months, 
by one of the psychiatrists belonging to both the Center and the Group. The diagnosis of 
refractory epilepsy was based on the definition of the International League Against 
Epilepsy[39]. 
Presurgical evaluation routinely included at least a video-electroencephalography (EEG) 
monitoring, a 3-Tesla brain magnetic resonance with an epilepsy protocol, a 
neuropsychological and a psychiatric evaluation. All patients underwent resective surgery.  
Data pertaining to demographic (gender, age, employment status, marital status, etiology of 
epilepsy, the topography of the epileptogenic zone, the age of onset, time to surgery), and 
Engel Class[210] after surgery, were collected during the interviews and from the patient`s 
medical and surgical records. In the pre-surgical period, patients were taking, at least, two 
antiepileptic drugs. However, the type, number, and dosages of the medications were not 
addressed in this study because of the usually broad variability among this population. 
Nonetheless, patients usually, continue to take the same drugs and maintain the same 
therapeutic schemes for at least 2 years, after surgery, if they stop having seizures. 
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This study was performed in accordance with the ethical standards of the 1964 Declaration 
of Helsinki, and its later amendments, and it was approved by the Ethics Committee of the 
Hospital de Santa Maria (CHULN).  
 
2.1 Subjects 
Participants older than 18 years, submitted to resective surgery, with a minimum of one year 
of education were included in the study. Participants that underwent Deep Brain Stimulation 
(DBS) or Vagus Nerve Stimulation (VNS), and those with other neurological diseases or 
intellectual disability, were excluded.  
A total of 196 consecutive people with refractory epilepsy, who were proposed for pre-
surgical evaluation, were enrolled in the study. Of those, 15 were secondarily excluded 
because of intellectual disability (QI<70), 48 were excluded because they did not undergo 
surgery, 12 were excluded because they underwent DBS or VNS, 1 refused to participate, 
and 1 died. Thus, a total of 124 individuals were included in the study.  
 
2.2 Psychiatric Evaluation 
Psychiatric evaluations included a clinical psychiatric history (demographic data, previous 
psychiatric history, family history, use of substances, as well as, other relevant data) and the 
following psychopathological tests:  
 
2.2.1 The Hamilton Anxiety Rating Scale (HARS) 
This scale consists of 14 items and measures both psychic and somatic anxiety[57]. 
It is scored according to the following cut-offs: 17 = mild; 18-24 = mild to moderate; 25-30 
= moderate to severe anxiety[57].  
 
2.2.2 The Hamilton Depression Rating Scale (HDRS) 
The version used corresponds to the original 17 items version. It was developed to access 
the severity of depressive symptoms[58] and the following scores were considered: 0-7 = 
normal; 8-16 = mild; 17-23 = moderate; >24 = severe depression[119]. 
 
2.2.3 Brief Psychiatric Rating Scale (BPRS) 
This rating scale is used to measure the change in psychiatric symptoms, particularly, 
psychotic symptoms. It contains 18 items, each one rated from 1 (absent) to 7 (extremely 
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severe), evaluating positive, negative and affective symptoms[59]. It ranges from 18 to 
126[211]. 
 
2.2.4 Symptom Checklist-90 (SCL-90) 
This multi-dimensional instrument is a 90-item self-report symptom inventory developed to 
measure psychopathological symptoms and psychological distress. It has been extensively 
validated. There are three global indices for the SCL-90: 1) Global Severity Index (GSI), 
which is the average score of the 90 items of the questionnaire; it is the best single indicator 
of the current level of the disorder, 2) Positive Symptom Distress Index, which is the average 
score of the items scored above zero, and 3) Positive Symptoms Total, which is the number 
of items scored above zero[61]. A cut-off of 0.57 was proposed[212]. 
Lifetime psychiatric disorder diagnostics were established according to the International 
Statistical Classification of Diseases and Related Health Problems (ICD-10)[117], including 
information provided by the patient and the family member who accompanied the pre-
surgical evaluation. 
 
2.3 Statistical Analysis  
The statistical analysis was conducted using Stata software (version 14.2; StataCorp, Texas, 
USA). Descriptive statistics were performed to report the analysis of data presented as mean 
± standard deviation or median (minimum-maximum). Student's t-test and the Mann-
Whitney U test were used for the parametric and non-parametric data, respectively. A chi-
square test, or the Fisher exact test in case of non-parametric data, was used to compare the 
categorical variables, which were given as the number of cases or proportions.  
The outcome variable considered was the Engel Class, registered 12 months, after surgery. 
Because this is an ordinal variable, an ordered logistic regression model was used for the 
univariate and multivariate analysis.  
First, a model was developed including lifetime psychiatric diagnosis, analyzed as a binary 
variable (at least one lifetime diagnosis versus no lifetime diagnosis); then as a categorical 
variable was created, according to the following diagnostic groups: no history of previous 
mental disorders, history of psychoactive substance use, any psychotic disorder, any mood 
disorder, any anxiety disorder, any other mental disorder.  
Measures of association were expressed as Odds Ratio (OR); and a p-value ≤0.05 was 





3.1  Demographic and clinical findings considering the existence of a lifetime 
psychiatric diagnosis versus no history of such diagnosis 
Comparing patients with and without a history of a lifetime psychiatric disorder, significant 
differences were found regarding their employment status. Those with a history of some 
psychiatric disorder had a lower probability of being active workers (p= 0.009). 
Approximately half of them were unemployed or had retired early. They also tended to have 
a right epileptogenic zone (p=0.007), a longer duration of disease (p=0.03), and a worse 
outcome after surgery (p=0.01). Other demographic and clinical characteristics are described 
in Table 10. 
 
Table 10 - Socio-demographical and clinical characteristics of the participants. 
 No lifetime 
psychiatric disorders 
N = 67 
At least one lifetime 
psychiatric disorder 
N = 57 
p-value 
Age, years 36.9 ± 11.8 40.4 ± 11.7 0.10 
Males, n (%) 29 (43.3) 21 (36.8) 0.47 
Education, years 11.0 ± 4.4 9.7 ± 4.6 0.11 
Active workers, n (%) 53 (79.1) 28 (52.8) 0.009 
Married, n (%) 35 (52.2) 27 (49.1) 0.29 
Age at onset, years 17.1 ± 11.2 15.3 ± 10.9 0.35 
Duration of epilepsy, years 19.9 ± 12.3 25.0 ± 13.7 0.03 
Temporal epileptogenic zone, n (%) 61 (91.0) 50 (89.3) 0.74 
• Mesial 53 (86.9) 43 (86.0) 
• Neocortical 8 (13.1) 7 (14.0) 
Extratemporal epileptogenic zone, n (%) 6 (9.0) 6 (10.7) 
Side of the epileptogenic lesion 
• Left 39 (58.2) 19 (33.9) 0.007 
• Right 28 (41.8) 37 (66.0) 
Type of epileptogenic lesion   0.68 
• Sclerosis 40 (65.6) 31 (62.0) 
• Tumors 13 (21.3) 9 (18.0) 
• Dysplasia 2 (3.3) 3 (6.0) 
• Gliosis 2 (3.3) 1 (2.0) 
• Cavernous angioma 2 (3.3) 2 (4.0) 
• Other 2 (3.3) 4 (8.0) 
Number of antiepileptic drugs 2.3 ± 0.6 2.2 ± 0.6 0.39 
Epileptic crises per month 6.8 ± 8.6 9.2 ± 16.9 0.48 
Engel I 58 (92.1) 39 (75.0) 0.01 
Engel II, III and IV 5 (7.9) 13 (25.0) 
 
3.2  Lifetime history of mental disorders 
Before surgery, a total of 57 candidates (46%) had a lifetime history of at least one mental 




Table 11 - Socio-demographical and clinical characteristics of the participants. 
No previous diagnosis, n (%) 67 (54.0) 
Depressive disorders, n (%) 36 (29.0) 
Anxiety disorders, n (%) 6 (4.8) 
Psychoactive substance use, n (%) 6 (4.8) 
Psychotic disorders, n (%) 3 (2.2) 
Other diagnosis, n (%) 6 (4.8) 
 
3.3 Psychopathology at the moment of pre-surgical evaluation 
At the pre-surgical evaluation, surgical candidates had a medium HDRS total score of 
7.69±7.56, a medium HARS total score of 8.32±7.09, a medium GSI total score of 
0.88±0.56, and a medium BPRS total score of 27.5±9.15. 
According to the defined cut-off for HDRS, 7 people had moderate depression and 13 people 
had severe depression at the moment of evaluation. Two patients had moderate to severe 
anxiety according to the HARS.  
 
3.4 Results from the univariate analysis 
The lifetime history of any mental disorder was a predictor of higher Engel Class scores one 
year after surgery (OR 3.83; CI 95% 1.27-11.59; p=0.017).  
Considering each group of disorders separately, a previous diagnosis of a psychotic disorder 
(OR 35.18; CI 95% 2.84-436.15; p=0.006) and any substance use disorder (OR 15.94; CI 




This cohort study was conducted in a reference center for refractory epilepsy using a sample 
of people who underwent epilepsy surgery. Our aim was to confirm that lifetime psychiatric 
disorders or psychopathology, detected at the pre-surgical evaluation, predict a worse post-
operative seizure outcome.  
Our data showed that 46% of epilepsy surgery candidates had a previous history of mental 
disorders. This high percentage tracks with previous studies[152,213] and argues for a close 
relationship between epilepsy and psychiatric disorders. 
Further, this study showed that patients with a history of mental disorders tend to have lower 
levels of success in the control of seizures after surgery. Depression, psychotic disorders and 
substance use disorders may have a higher negative impact.  
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Previous researchers have also investigated the relationship between pre-operative 
psychopathology or major psychiatric disorders and the probability of seizure remission after 
epilepsy surgery. However, the results were controversial. Koch-Stoecker et al. (2017) 
concluded that a lifetime diagnosis of psychosis, major depression, or personality disorders 
diminished the probability of complete seizure remission[214]. Additionally, Kanner et al. 
(2009) studied presurgical lifetime history of mood, anxiety, attention deficit hyperactivity, 
and psychotic disorders as independent predictors of seizure outcome and suggested that a 
lifetime psychiatric history may predict worse post-operative seizure control[206]. Adams 
et al. (2012) found no association between psychiatric history and seizure outcome on 
patients with mesial sclerosis. These contradictions, however, may be due to the analysis of 
a small sample (n=72). Another potential explanation was provided by the authors, namely 
that the association found in previous literature may be due to the inclusion of patients with 
other diseases besides mesial sclerosis in their samples. Lifetime psychiatric disorders would 
predict worse outcomes in this group of people but not in mesial sclerosis patients[208]. Our 
sample includes both patients with and without mesial sclerosis. Lackmayer et al. (2013) 
also found that pre-operative depressive symptoms were not predictors of post-operative 
seizure control in people with temporal lobe epilepsy. However, their sample size was also 
small (n=45)[209].  
The association between pre-operative psychiatric lifetime diagnosis and seizure outcome 
could, as mentioned, be related to psychological factors or common biological mechanisms. 
Long-lasting refractory epilepsy may cause more brain dysfunction and contribute to both 
psychiatric disorders and a reduced probability of seizure remission.  
Our study has some limitations. This was an observational study with a retrospective 
component, so some data were missing. Different sources of information were considered in 
order to confirm clinical information and to complete data as much as possible. Another 
limitation was that lifetime psychiatric diagnosis may not have been reported for several 
reasons, some including the fact that some psychopathological symptoms may be considered 
as a “natural reaction” to epilepsy or because of their fear of not being qualified for surgery. 
Consequently, this may have affected our results. However, information was, whenever 
possible, confirmed with family members and other accompanying persons. We did not 
control for the type of antiepileptic drugs; these may have an impact on mood and behavior. 
Nevertheless, we do not expect to have significant differences in therapeutic schemes 
between patients with and without psychiatric comorbidities as they are mainly determined 
by their efficacy on the control of epilepsy regardless of this type of comorbidity. We also 
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did not include in our analysis the use of psychiatric medications, although we might expect 
that all patients with moderate to severe symptomatology were medicated. Finally, we 
considered the 12-month outcome; while a 24-months assessment would be more adequate 
to evaluate seizure outcome. 
Despite these constraints, our study shows a clear relationship between epilepsy and mental 
disorders, arguing for a bidirectional relationship. Patients with psychiatric disorders and 
epilepsy may represent a group with more generalized brain dysfunction and a potentially 
more serious disorder. Previous psychiatric history should always be identified and included 
in an evaluation protocol that would help clinicians and surgery candidates to have a more 
accurate prediction of the potential success of the surgery. 
Unfortunately, until recent years, psychiatric comorbidities were frequently not considered 
or treated. The recognition of their impact on the quality of life and on the clinical course of 
epilepsy has highlighted the need for early identification and treatment of psychiatric 
disorders[215].  
Future studies should focus on the impact of pharmacological or psychosocial treatment of 
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Abstract 
Objectives  The aim of this study was to build a predictive model for epilepsy surgery 
outcome including epilepsy-related and psychiatric predictors. 
Methods  We conducted an ambispective observational study with the inclusion of 
people who underwent resective surgery, Deep Brain Stimulation (DBS) or 
Vagus Nerve Stimulation (VNS). Participants were evaluated before and one-
year after surgery to collect data regarding their neurological and psychiatric 
history. The one-year postsurgical outcome was classified according to the 
Engel Outcome Scale. Predictors of post-surgical Engel class were included 
in a multivariate logistic regression model. Then the accuracy of different 
predictive models combining different predictive factors was tested.   
Results  Predictors of higher Engel Class were a lifetime history of any mental 
disorder (OR 3.96; CI 95% 1.36-11.46; p=0.011), an extratemporal 
epileptogenic zone (OR 4.12; CI 95% 1.12-15.11; p=0.033) and DBS or VNS 
(OR 83.69; CI 95% 13.62-514.04; p<0.001). A model including gender, 
duration of epilepsy, age at the beginning of epilepsy, type of surgery and 
history of any lifetime psychiatric disorder achieved an area under the ROC 
curve of 0.81.  The single most important contributor to the accuracy of the 
model was a history of any lifetime mental disorder. 
Conclusion  Simple predictors may be used to predict epilepsy surgery outcome with a 
good accuracy. Psychiatric lifetime diagnoses are important predictors of a 
worst surgical outcome and should be included in the decision-making 
process to determine the potential success of the surgery. 




Epilepsy surgery may be a potential life-changing treatment for those living with refractory 
epilepsy. In focal epilepsies, the gold-standard is the resective surgery[216]. Up to 80% of 
patients may achieve seizure freedom patients after the resection of the epileptogenic zone 
[217]. Mesial temporal sclerosis is the most common form of focal epilepsy; therefore, the 
majority of these patients undergo temporal resection[218]. The goal of this procedure is to 
remove the epileptogenic zone completely without any subsequent permanent neurological 
damage[218].  
About a third of those with refractory epilepsy are not suitable for resective surgery, this 
may be due to clinical factors, such as the type of seizure and location of the epileptogenic 
zone [219]. These patients may benefit from other types of surgery, also called, palliative 
procedures, such as the stereotactic surgery or the neuromodulation techniques, including 
the Vagus Nerve Stimulation and the Deep Brain Stimulation. Despite a seizure-free 
outcome is not expected, benefits in terms of seizure frequency and severity have been 
reported[220,221]. 
Considering the outcome of resective surgery, some prognostic factors have been identified. 
Abnormalities in the pre-operative Magnetic Resonance Imaging (MRI), complete surgical 
resection, presence of tumor or mesial temporal sclerosis, right-side resection, history of 
febrile seizures, and unilateral spikes are some of the factors associated with a better 
prognosis[222]. No evidence was found regarding other factors such as the presence of post-
operative discharges or a history of head injury[222]. Poorer prognosis may be predicted by 
other clinical characteristics such as bilateral Positron Emission Tomography (PET) 
abnormalities and acute post-operative seizures[223].  
Nonetheless, despite the identification of multiple prognostic factors and the development 
of some prognostic models, the accuracy of the prediction of epilepsy surgery outcome, 
using clinical judgment or published statistical tools, is still low[217]. 
Besides epilepsy related features, other factors such as the presence of a psychiatric lifetime 
disorder has been identified as an important predictor of epilepsy surgery outcome[116]. 
Still, none of the multi-variable prognostic models that have been published included this 
clinical factor or considered its relative importance for the accuracy of the model.  
More accurate and comprehensive models, including both clinical and nonclinical variables, 
are needed to guide the decision-making process[217]. In our work we developed different 
predictive models, including lifetime psychiatric diagnosis as well as other surgery and 
epilepsy-related factors to determine its relative importance to the accuracy of the model.  
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2 Methods  
We conducted an ambispective cohort study at the Neurosciences and Mental Health 
Department of our Institution, between April 2000 and September 2018. Adults with a 
diagnosis of refractory, according to the definition of the International League Against 
Epilepsy [39], were included, consecutively, from both our Refractory Epilepsy Reference 
Centre and Epilepsy Surgery Group. Those with other neurological diseases or intellectual 
disability were excluded.  
The pre-surgical assessment included a video-electroencephalography (v-EEG) monitoring, 
a 3-Tesla brain magnetic resonance with an epilepsy protocol, a neuropsychological and a 
psychiatric evaluation. The determination of the epileptogenic zone was made by consensus. 
Invasive techniques and other exams such as PET were used when the routine assessment 
was considered insufficient. Most patients underwent resective surgery and a smaller 
proportion was treated with Deep Brain Stimulation of the anterior nucleus of the thalamus 
(ANT-DBS) or Vagus Nerve Stimulation (VNS).  Demographic and clinical data (gender, 
age, employment status, marital status, etiology of epilepsy, the topography of the 
epileptogenic zone, the age of onset, time to surgery), as well as Engel Class[210] one-year 
after surgery, were collected during interviews and from medical and surgical records. 
Psychiatric assessment was performed by one of the psychiatrists from the Refractory 
Epilepsy Reference Centre and Epilepsy Surgery Group. Lifetime psychiatric disorder 
diagnostics were established according to the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10)[117]. This study was approved by the 
Ethics Committee of Hospital de Santa Maria. Methods have been described in detail 
elsewhere(cit.). 
 
2.1 Statistical Analysis  
The statistical analysis was executed using Stata software (version 14.2; StataCorp, Texas, 
USA). Descriptive statistics were presented as mean ± standard deviation. Student's t-test 
and the Mann-Whitney U test were used for parametric and non-parametric data, 
respectively. A chi-square test, or the Fisher exact test in case of non-parametric data, was 
used to compare categorical variables.  




The outcome variable was the Engel Class registered 12 months, after surgery. As it should 
be binary, a new variable was generated for the Engel Class - Engel class 1 versus Engel II, 
III or IV. 
Predictors included duration of disease and age of onset of epilepsy, analyzed as continuous 
variables; gender, temporal versus extratemporal epileptogenic zone and type of surgery 
(resective surgery versus VNS or ANT-DBS), analyzed as binary variables; laterality of the 
epileptogenic zone, analyzed as a categorical variable.  
Finally, we compared the area under the receiver operating characteristics curve (AUC of 
ROC) and used the Delong method to test the performance of the predictive models. The 
best performance was searched using backward selection for each of the chosen predictors.  
Measures of association were expressed as Odds Ratio (OR) and a p-value ≤0.05 was 
considered statistically significant. 
 
3 Results 
3.1  Demographic and clinical findings considering the existence of a lifetime 
psychiatric diagnosis versus no history of such diagnosis  
One hundred and ninety-six consecutive people with refractory epilepsy were enrolled. 
Fifteen were secondarily excluded because they had intellectual disability, 48 did not 
underwent surgery, 1 died and 1 refused to participate. Thus, a total of 136 individuals were 
included in this study. Demographic and clinical characteristics of the sample were described 
in Table 12. 
 
Table 12 - Socio-demographical and clinical characteristics of the participants. 
AGE, YEARS 38.2 ± 11.7 
MALES, N (%) 67 (42.4) 
EDUCATION, YEARS 10.2 ± 4.5 
ACTIVE WORKERS, N (%) 93 (64.6) 
MARRIED, N (%) 74 (50.0) 
AGE AT ONSET, YEARS 15.5 ± 11.1 
DURATION OF EPILEPSY, YEARS 22.8 ± 13.2 
TEMPORAL EPILEPTOGENIC ZONE, N (%) 139 (89.1) 
• MESIAL 96 (86.5) 
• NEOCORTICAL 15 (13.5) 
EXTRATEMPORAL EPILEPTOGENIC ZONE, N (%) 17 (10.9) 
SIDE OF THE EPILEPTOGENIC FOCUS  
• LEFT 74 (47.1) 
• RIGHT 76 (48.4) 
• BILATERAL 7 (4.5) 
NUMBER OF ANTIEPILEPTIC DRUGS 2.3 ± 0.6 
TYPE OF SURGERY, N (%)  
• RESECTIVE SURGERY 145 (91.8) 
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• DBS OR VNS 13 (8.2) 
ENGEL I 98 (79.0) 
ENGEL II, III AND IV 26 (21.0) 
 
 
3.2 Results from the multivariate analysis 
The factors associated with a higher Engel Class were a lifetime history of any mental 
disorder (OR 3.96; CI 95% 1.36-11.46; p=0.011), having an extratemporal epileptogenic 
zone (OR 4.12; CI 95% 1.12-15.11; p=0.033) and being submitted to ANT-DBS or VNS 
(OR 83.69; CI 95% 13.62-514.04; p<0.001). 
 
3.2 Results from the prediction models 
Without the inclusion of the variable lifetime psychiatric history, the model showed an area 
under the ROC curve of 0.71 showing poor accuracy. However, when lifetime psychiatric 
history was included, this area improved to 0.76, considered a fair accuracy. 
These results were confirmed using the DeLong method. 
After testing for different models combining the variables, the best performance was 
achieved eliminating laterality and location of the epileptogenic focus and keeping all the 
other predictors. The area under the ROC curve of the final model was 0.81, showing good 
accuracy. 
The single most important contributor to the accuracy of the model, showing a greater 
improvement of the ROC area, was the history of a lifetime psychiatric diagnosis.  
Figure 21 and 22 illustrates the model with and without the inclusion of lifetime psychiatric 
diagnosis. 
Figure 21 - Area under the Receiver Operating Characteristic (ROC) curve of the model without the 
















0.00 0.25 0.50 0.75 1.00
1 - Specificity








Figure 23 illustrates the comparison of ROC area in both models using the DeLong method.   
 
Figure 23 - Comparison of models using the DeLong method. 
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Figure 24 - Final model including gender, duration of epilepsy, age at the beginning of epilepsy, type of 





This cohort study allowed the development of a predictive model that showed good 
discrimination between those with a better outcome (Engel I) and those with a poorer 
outcome (Engel II to IV) using simple clinical and demographical characteristics. These 
variables included the gender, the duration of epilepsy, the age at the beginning of epilepsy, 
the type of surgery and the existence or not of any lifetime psychiatric disorder.  
The most significant predictors of a poorer seizure outcome were a lifetime history of any 
mental disorder, an extratemporal epileptogenic zone and the type of surgery being ANT-
DBS or VNS. 
A lifetime psychiatric history was recently found to constitute a predictor of epilepsy surgery 
outcome[116] (Novais et al. 2019), however, it has not been included in prognostic models 
yet. Our study shows that this is an important contributor to the accuracy of the outcome 
prediction and, although it should not preclude the surgery, a psychiatric disorder history 
must be included in the multidisciplinary discussion regarding the potential outcome of 
epilepsy surgery.  
People with refractory epilepsy and psychiatric comorbidity may have more widespread 
brain abnormalities such as the dysfunction of glutamate, serotonin, dopamine, and y-
aminobutyric acid transporters[1,22,25]. These abnormalities may be secondary to the 
epileptogenic activity, to the psychiatric disorder or constitute a common ground for both. 
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zone may not lead to seizure freedom as we would expect in other patients with the same 
characteristics but without a psychiatric history.  
 Regarding the type of surgical procedure, as we expected, ANT-DBS and VNS were 
associated with higher Engel classes. These neuromodulation techniques, considered as 
palliative procedures, are linked with considerably lower rates of seizure control when 
compared to resective surgery[224].  
Additionally, in our sample, the extratemporal epileptogenic zone was correlated with a 
lower probability of disabling seizures remission. This result also confirms previous 
findings[203,225]. 
Recently, Gracia et al. (2019) compared the accuracy of clinical judgment in predicting 
epilepsy surgery outcome to two previously published statistical tools, the Epilepsy Surgery 
Nomogram (ESN) and the modified Seizure-Freedom score (m-SFS)[217]. Using a ROC 
curve analysis for the prediction of seizure control at 2 and 5 years, these authors found that 
the AUC curves were approximately 0.48 and 0.47, respectively, when the clinicians´ 
judgment was considered. The m-SFS, that included the variables: preoperative seizure 
frequency, history of generalized tonic-clonic seizures, brain magnetic resonance imaging 
(MRI), and epilepsy duration[226], showed an AUC of, approximately, 0.54, at both time 
points. While the ESN, witch considered the following predictors: sex, seizure frequency, 
secondary seizure generalization, type of surgery, pathological cause, age at epilepsy onset, 
age at surgery, epilepsy duration at time of surgery, and surgical side[227], showed an AUC 
curve of, approximately, 0.53, also at both time points[217]. The authors found no statistical 
differences between the ESN and the clinicians or between m-SFS and the ESN and they all 
showed a very poor ability to predict the surgery outcome, reinforcing the need for better 
predictors[217]. The variables chosen in our model allowed the development of a model 
with an AUC curve of 0.81 including only some of the available predictors and the presence 
of any lifetime psychiatric disorder. Therefore, we were able to identify the predictors that 
might contribute the most to the prediction of epilepsy surgery outcome. 
Moreover, the fact that we used a broad clinical sample allowed us to identify predictors that 
apply to patients with very different clinical characteristics.  
Some limitations of this work must be considered. This work has a retrospective component, 
so some data were lost. We believe that they are missing completely at random, also different 
sources of information were used to complete information as much as possible. Lifetime 
psychiatric diagnosis may not have been reported because of some reasons that include the 
fact that some psychopathological symptoms may be considered as a “natural reaction” to 
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epilepsy or because of their fear of not being qualified for surgery. To address this potential 
problem, information was, whenever possible, confirmed with family members and other 
accompanying persons. We also did not include in our analysis if patients have been treated 
or not for their psychiatric condition, therefore we do not have information whether treating 
these conditions would have an impact on epilepsy course. Lastly, we also did not test or 
include in our model other predictors of epilepsy surgery outcome that have been identified 
in previous literature. However, despite their identification as potential predictors, their 
relative contribution to the accuracy of a predictive model has not been determined. Our 
study shows that, in fact, a good accuracy may be achieved with simple, although more 
inclusive, predictors. 
Epilepsy surgery may be more or less invasive but there are always potential harms to 
consider. It is imperative for both doctors and patients to be able to take an informed decision 
about whether or not to proceed. Predictive models and the development of predictive tools 
may help epilepsy teams to have a more precise estimate of the seizure outcome after 
surgery. 
Future studies, with bigger samples, should test this model and potentially develop simple 


















SUMMARY OF THE MAIN FINDINGS  
 
STUDY 1 
Question 1: What is the percentage of people with refractory epilepsy that also have a 
history of any mental disorder? 
Question 2: What are the most frequent psychiatric disorders in people with refractory 
epilepsy? 
Question 3: Are there any epilepsy related factors that may increase the risk for psychiatric 
disorders? 
Forty-six percent of our sample had at least one previous psychiatric diagnosis, most 
frequently depressive (64%), anxiety (10%), substance use (10%) and psychotic disorders 
(6%).  
Patients with a right-side epileptogenic zone had an increased risk for these disorders (OR 
2.36; CI 1.22-4.56; p=0.01). 
 
STUDY 2 
Question 4: What is the percentage of people with a dysfunctional personality pattern in 
those with refractory epilepsy? 
Question 5: Does the affection of different brain lobes contribute to different types of 
personality disorders?  
Question 6: Is the epilepsy surgery associated with a reduction on the proportion of people 
with dysfunctional personality patterns? 
Seventy percent of the participants of the study had a dysfunctional personality pattern 
before surgery. After surgery, this percentage dropped to 58%. The difference was 
statistically significant after adjusting for potential confounders (p=0.013).  
The most common types were Cluster C personality patterns.  
Temporal epileptogenic zone was a significant predictor of higher scores of the Avoidant 
(Coef. 11.8; CI -0.59 23.7; p=0.051) and Compulsive (Coef. 9.55; CI 2.48 16.6; p=0.008) 
personality patterns and lower scores of Histrionic (Coef. -11.4; CI -21.2 -1.55; p=0.024) 
and Antisocial (Coef. -8.4; CI -15.6 -1.25; p=0.022) personality patterns, compared to 





Question 7: What is the percentage of people developing de novo psychiatric disorders after 
epilepsy surgery? 
Question 8: Are there any epilepsy or surgery-related factors that could increase the risk 
for de novo disorders? 
Sixteen people (15%) developed psychiatric disorders that were never identified before 
surgery. Multilobar epileptogenic zone (p=0.001) and DBS of the anterior nucleus of the 
thalamus (p=0.003) were found to be significant predictors of these events. 
 
STUDY 4 
Question 9: Considering those who already had some degree of psychiatric symptomatology 
are there any factors that could predict the worsening or the improvement of 
their mental symptoms, after surgery? 
Bilateral epileptogenic zone, lack of remission of disabling seizures and Deep Brain 
Stimulation, targeting the anterior nucleus of the thalamus (ANT-DBS), were the most 
important predictors of an increase in SCL-90 scores, after surgery. 
 
STUDY 5 
Question 10: Does a lifetime history of any psychiatric disorder predicts worse epileptic 
seizures control after surgery?  




Question 11: What is the relative importance of having a history of any psychiatric disorder 
in a predictive model of epilepsy surgery outcome? 
A model including gender, duration of epilepsy, age at the beginning of epilepsy, type of 
surgery and history of any lifetime psychiatric disorder achieved an area under the ROC 
curve of 0.81. The most important contributor to the accuracy of the model was a history of 





RELIABILITY OF QUESTIONNAIRES  
We calculated the Cronbach's alpha from both SCL-90 (Table 13) and MCMI-II (Table 14), 
the two questionnaires used in our studies. This is a widely used an accepted statistical 
measure that allows the determination of the internal consistency of a test. It measures the 
pairwise correlations between items. Negative values show that the within-subject variability 
is higher than between-subject variability. Values from 0.7 to 0.8 show an acceptable internal 
consistency, from 0.8 to 0.9 it is considered good and above 0.9 the test shows an excellent 
internal consistency[63,64].  
 
Table 13 – SCL-90 Cronbach's alpha 
Personality scales Cronbach's alfa Number of items 
Pre-surgery 1-year after surgery 
Somatization 0.87 0.89 12 
Obsessive-compulsive 0.86 0.94 10 
Interpersonal sensitivity 0.83 0.85 9 
Depression 0.88 0.94 13 
Anxiety 0.81 0.92 10 
Hostility 0.70 0.75 6 
Phobic Anxiety 0.80 0.84 7 
Paranoid Ideation 0.76 0.81 6 
Psychoticism 0.81 0.88 10 
Global Severity Index 0.97 0.99 90 
 
Table 14 – MCMI-II Cronbach's alpha 
Personality scales Cronbach's alfa Number of items 
Schizoid 0.99 35 
Avoidant 0.99 41 
Dependent 0.99 37 
Histrionic 0.99 40 
Narcissistic 0.99 48 
Antisocial 0.99 45 
Aggressive 0.99 45 
Self-defeating 0.99 40 
Schizotypal 0.99 44 
Borderline 0.99 62 
Paranoid 0.99 43 




















The study of mental disorders in PWE began many decades ago, since then there was a sense 
of connection between these two types of disorders that has yet to be fully determined. 
There is an established high prevalence of psychiatric disorders in epilepsy[9] and apparently 
a higher risk of epilepsy[33] in people with psychiatric disorders.  
In this work, we searched for evidence of a bidirectional relationship. Many approaches 
could be used to study this theme. We opt to divide our work in to two parts; on our first 
four studies, in order to determine the influence of epilepsy-related features and epilepsy 
surgery on mental disorders, we focused on the study of the predictors and risk factors for 
mental disorders in RE people, before and after epilepsy surgery. Then, in our last two 
studies, we aimed to determine the influence of mental disorders on the course of epilepsy 
studying them as a potential determinant of the post-surgical course of epilepsy and its role 
on a predictive model.  
In the first study of this thesis we intended to characterize lifetime psychiatric diagnosis 
identified at the pre-surgical interviews and their epilepsy-related predictors. We found that 
forty-six percent of our sample had at least one previous psychiatric diagnosis, most 
frequently depressive (64%), anxiety (10%), substance use (10%) and psychotic disorders 
(6%). These data are in line with previous literature and reinforce the fact that this is a 
frequent comorbidity in refractory epilepsy[86]. Moreover, we identified that an 
epileptogenic zone located on the right cerebral hemisphere doubles the risk for this 
comorbidity, reinforcing previous literature that points to an important role of the right 
hemisphere on emotional processing[89]. 
In study 2, we focused in the personality patterns of patients with RE. For this analysis we 
used the Millon Clinical Multiaxial Inventory II (MCMI-II) that defines 13 personality 
profiles. Our objective was to determine if the epileptogenic zone was a predictor of the 
personality profiles of surgical candidates. Many of the previous studies, focusing the 
personality patterns in PWE, aimed to determine if there was a distinguished personality 
profile similar to the one described by Geschwind, using Bear and Fedio questionnaire[7] or 
other different questionnaires[228,229]. Many also used mixed samples of people with 
temporal and extratemporal epilepsy[230]. There is a high variability in these studies and a 
consistent pattern of personality has not been found yet[231]. 
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Our results showed that 70% had a score higher than the cut-off value of 85, in at least one 
of the personality patterns, meaning that there was a persistence of dysfunctional traits in a 
high percentage of our sample. The majority of them had a mixed pattern of traits from 
different personality patterns, most commonly, corresponding to personality types from the 
Cluster C of the DSM-5. 
After surgery, only 58% had a score above the cut-off value, suggesting that the surgery 
might have some protective effect, possibly due to the reduction of epileptogenic discharges 
or the removal of dysfunctional brain areas.  
Moreover, we showed that surgery candidates have a distinct profile pattern according to 
their epileptogenic zone. Those with temporal epileptogenic zones had higher scores of two 
personality patterns corresponding to the DSM cluster C personality patterns – “Avoidant” 
and “Compulsive” and those with extratemporal epileptogenic zones had higher scores in 
personality patterns corresponding to cluster B personality patterns – “Histrionic” and 
“Antisocial”. Despite their heterogeneity, some previous data may be in line with these 
findings. Our extratemporal group was manly constituted by people with a frontal 
epileptogenic zone that has been associated with impulsivity and antisocial behavior, while 
the so-called “interictal personality disorder”, associated with people with a temporal lobe 
epileptogenic zone, has some resemblance with the cluster C personality disorders, described 
in the DSM-5[232–235]. 
The objective of study 3 was to determine predictors of de novo psychiatric syndromes 
during a follow-up period of 3-years. For this analysis, we used a survival model examining 
time-to-event and defined the event as being the first major psychiatric syndrome in people 
without any history of those type of disorders, before surgery.  
Our results showed that 15% of our sample developed de novo events. This relatively high 
rate of psychiatric adverse events is superior to the majority of other secondary events[222] 
and should always be taken into account when discussing the risks of the surgery with 
patients. The mean time until the first psychiatric event was 13 months and the median was 
7 months, showing that there is a highest risk in the first year, after the procedure.  
Moreover, we showed that those with a multilobar epileptogenic zone and those submitted 
to ANT-DBS had a much higher risk of developing new psychiatric disorders and tend to 
develop them earlier.  
Epilepsy surgery is a treatment that has the potential to modify significantly the course of 
epilepsy and may be even curative. However, an invasive procedure, such as epilepsy 
surgery, causes some degree of injury inflicted on the normal and functional brain while 
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dissecting the pathological tissue. This causes at least some transitory neuroinflammation 
and axotomy[236]. After the procedure, some reorganization of brain cells and circuits 
probably take place. These processes may cause some degree of distress increasing the risk 
for post-surgical psychopathology. However, other potential explanations should be 
considered. Recently, Salpekar(2019), in a paper dedicated to the analysis of our study 3, 
addresses the difficulties faced by researchers regarding the study of this theme and proposes 
three mechanisms that may explain de novo psychopathology[237]. The first is, as we also 
stated, that psychiatric disorders may be underreported at the first assessment. The second is 
that the occurrence of epileptic seizures interrupted by the surgery could have some previous 
therapeutic effect. For example, in the case of depressive and psychotic symptoms, a 
phenomenon already discussed by other authors and consistent with the theory of forced 
normalization. Finally, the possibility that, after the removal of the epileptogenic focus, 
“depressogenic” tissues may be left untouched. The author also proposes that psychiatric 
illnesses may be inherent or a constituent part of epilepsy[237]. This suggestion is consistent 
with our findings. 
Our study was the first to include a sample of RE people submitted to RS and ANT-DBS. 
The use of DBS for the treatment of RE is relatively recent and its risk of psychiatric adverse 
events, when compared to more conventional methods such as the RS, was not yet clarified. 
There are some studies showing that there might be some risk of worsening depressive 
symptoms but results are controversial and generally focused only on mood changes. Fisher 
et al. (2010) showed that more patients submitted to ANT-DBS report depression, when 
compared to control subjects, however, they referred that the difference was not reflected in 
the neuropsychological tests used[238]. Järvenpää et al. (2018) stated that the majority of 
patients did not had adverse psychiatric events in their group of 22 people submitted to ANT-
DBS, however, 2 patients with no previous history developed clear paranoid symptoms after 
the procedure[239]. In an eleven year follow-up study, 17% of patients developed 
depression, about 7% had suicidal ideation and 1 patient committed suicide but this was not 
considered to be “device-related”[240]. 
Tröster et al. (2017), from the SANTE study group, reported no significant worsening of 
depression scores during 7 years of follow-up[149]. However, in the same cohort, a rate of 
37.3% of depression events was reported and 11.8% had suicidal ideation, at some point, 
during the first 5-years of follow-up. No other adverse psychiatric events are described[241]. 
We showed that, in comparison to the more conventional RS, there is an about 7 times higher 
risk of developing psychiatric disorders, after surgery. In our sample, 40% of those submitted 
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to DBS developed some major psychiatric disorder that was never identified before surgery, 
all during the first 6 months after surgery. Showing a higher rate compared to what was 
previously reported and a considerable risk of psychiatric adverse events, after this type of 
procedure, when compared to conventional surgery. This difference may be due to the fact 
that all patients, from our center, are closely followed by psychiatrists while in centers were 
this is not the rule there might be some degree of underreporting. Other potential reasons 
may be related to differences in the execution of the technique, modulation parameters or 
other uncontrolled factors. The fact that most of the samples are small also leads to higher 
variation among them.  
The study 4, lead us to conclude that this neuromodulation technique is not only is a risk 
factor for de novo psychiatric syndromes but is also associated with worst 
psychopathological scores, measured by SCL-90, a widely used instrument that allows the 
evaluation of an inclusive group of symptom dimensions. This study focused on the 
determination of clinical predictors of psychopathological outcomes, one year after surgery. 
Considering the entire group of patients, no significant differences were found. However, 
when we did our subgroup analysis, we verified that while some patients improved other 
specific groups increased their scores. These differences were explained by clinical factors. 
The most important, with an impact in all symptom dimensions, was Engel Class II when 
compared to Engel Class I. No significant results were found considering class III and IV 
probably because of lack of power to detect these differences as very few patients were in 
these groups. 
Although there are very few studies evaluating psychiatric outcomes after RS and even fewer 
after ANT-DBS, our results are in line with previous data regarding RS and show that 
patients without seizures remission suffer from higher psychological distress after 
surgery[158,242]. Some explanatory hypothesis may be considered. An Engel Class II 
means that the patient continues to have disabling seizures, although, less frequently than 
before surgery. So, one problem might be the unmet expectations of the patient when they 
keep having seizures after the procedure, that may lead to feelings of frustration, anxiety and 
sadness. The first year after surgery is a difficult time as patients have to adapt emotionally 
and functionally. A good psychosocial outcome is not necessarily dependent just on a good 
seizure outcome, instead, a “successful” surgery should be a combination of both an 
acceptable and expected seizure status as well as the individual's perception of improvements 
in quality of life. The concept of “burden of normality” reflects the idea that a patient might 
face difficulties while abandoning sick roles and adapting his identity and environment after 
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the attenuation or cessation of a chronic illness, such as epilepsy[243]. Biological 
phenomena such as forced normalization[244], continued interictal epileptogenic discharges 
after the brain surgery, or post-injury neural response cascade, a phenomena that denotes the 
period of hypometabolism that occurs soon after and persists for a period, after a brain 
injury[245], may also constitute vulnerability factors for the development or worsening of 
psychopathological symptoms.  
This study also showed that both a multilobar and a bilateral epileptogenic zone were 
associated with higher scores in many SCL-90 dimensions. Therefore, in patients with an 
epileptogenic zone that is not confined to a unilateral and single lobe and there is a 
potentially wider dysfunction of the central nervous system, the removal of a particular brain 
area may not eliminate the risk and potentially even increase it because of the transitory 
neuroinflammation and axotomy caused by the surgery. 
In the second part of this thesis we focused on the determination of the influence of 
psychiatric disorders in the course of epilepsy after surgery. 
In our fifth study we aimed to determine if a lifetime history of any mental disorder might 
constitute a predictor of the epilepsy surgery outcome. For this purpose, we included the 
same cohort from our RE Center and used an ordered logistic regression model. We also 
included other potential determinants of outcome in our model. 
Predictors of higher Engel Class were, as expected, an extratemporal epileptogenic zone, 
cited by many authors as a predictor of worst outcome[203,225] and ANT-DBS or VNS, 
considered palliative procedures[224]. More interestingly, a pre-surgical history of mental 
disorders was a predictor of higher Engel class after surgery, confirming our hypothesis.  
Considering the findings from our study 3 and study 4, showing that a potential multilobar 
or bilateral dysfunction, associated with the epileptogenic zone, lead to a higher risk of 
psychopathology, after surgery, we may hypothesize that there is a subgroup of patients with 
a more serious neuropsychiatric disorder, associated with more widespread brain 
dysfunction. These people may have more psychiatric disorders and worse course of 
epilepsy leading to a poorer global prognosis. The mechanisms underlying this dysfunction 
may cause both disorders or can be subsequent to one of them. We may even hypothesize 
that both conditions are part of the same neuropsychiatric disorder manifesting itself with 
different symptoms in the course of time.  
Then, we developed a sixth study to determine the relative importance of psychiatric 
disorders as a predictor of epilepsy surgery outcome in a comprehensive model. To access 
this question predictors of post-surgical Engel Class were included in a multivariate logistic 
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regression model. Then we tested the accuracy of some predictive models combining 
different factors potentially associated with the surgery outcome.   
The best accuracy model found included gender, duration of epilepsy, age at the beginning 
of epilepsy, type of surgery and history of any lifetime psychiatric disorder, as predictors. 
The most important contributor to the accuracy of the model was a history of any lifetime 
mental disorder. Therefore, this study shows that this is an important contributor to the 
accuracy of the outcome prediction and, although it should not preclude the surgery, a 
psychiatric disorder history must be included in the multidisciplinary discussion regarding 
the potential outcome of epilepsy surgery. According to our knowledge, this was the first 
study to include mental disorders as a predictor in a predictive model for epilepsy surgery. 
Furthermore, considering this variable, we were able to develop a model with a much 
superior accuracy than other recently published models and clinical judgment only[217].   
 
General Limitations 
Besides the limitations discussed in each study, we consider that there were some general 
limitations of our work that we would like to point out. 
Firstly, it was based on observational and ambispective studies, with an important 
retrospective component. The main reason for this was the fact that, at our center, more than 
a half of the operated people are children which means that less adults would be available to 
be included in prospective studies. Since we needed a sample considered large enough to 
test our hypothesis, we decided to use also retrospective data. Different sources of 
information were reviewed in order to achieve the most complete and accurate data.  
Secondly, in our research we used 6 standardized instruments, namely, the Hamilton Anxiety 
Rating Scale (HARS), the Hamilton Depression Rating Scale (HDRS), the Brief Psychiatric 
Rating Scale (BPRS), the Symptom Checklist-90 (SCL-90), the Millon Clinical Multiaxial 
Inventory II (MCMI-II) and The Wechsler Adult Intelligence Scale (WAIS-III). This battery 
was defined according to the 1st Steering Committee meeting Epilepsy Registry and has 
been applied to every adult surgery candidate since 1999. Since then, more recent versions 
of BPRS, SCL-90 and MCMI-II have been developed, however, we decided to keep the 
same version in order to have a comparable test across all sample. Although they have been 
widely used to evaluate clinical samples, there isn´t any published validation of these scales 
and questionnaires and this is an important limitation. There is a scarcity of validated 
instruments, in Portugal, for the evaluation of psychopathology in medical patients and many 
of those that have been validated were published after the beginning of the assessments of 
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this sample. Despite, the lack of validation, both SCL-90 and MCMI-II showed good internal 
consistency measures as shown in the results section of this thesis. 
Thirdly, despite its paramount importance on the development of mental disorders, 
psychosocial factors were not measured or included in the analysis. However, we believe 
that the amount of personal, family and social burden is probably equally distributed in the 
sample. Also, despite the fact that, in the initial protocol, there was a questionnaire that 
should evaluate quality of life it was not included in our studies because of incompleteness 
and lack of data. Future studies should definitely include these types of variables. 
Finally, another limitation was that some subgroups had few patients limiting the power to 
detect differences in some studies.  
 
General Strengths and Scientific Interest 
The most important strengths of our work were that it was based on a Portuguese clinical 
sample, collected in the setting of usual medical care, in a Reference Center for the treatment 
of RE. It also comprised a broad sample constituted by surgical candidates with distinct 
clinical characteristics and submitted to different types of surgical interventions, adequately 
controlled, allowing for the transposition of these results to clinical practice. 
We used adequate methods and new analytic approaches to explore new questions or poorly 
investigated ones. 
We also showed innovative results that may have clinical implications and contributed to 
the clarification of some previously investigated but still controversial questions. In general, 
our results showed evidence to support the bidirectional relationship between refractory 
epilepsy and mental disorders according to our initial objective. We showed that there is an 
increased risk of psychiatric disorders when the right hemisphere is affected and the 
distinctive patterns of personality according to the epileptogenic zone. We also identified 
that a more widespread brain dysfunction contributes to psychopathology, as well as, 
continued disabling seizures, after surgery. Moreover, we demonstrated that ANT-DBS is 
not as benign, from the psychopathological point of view, as it seemed in the first studies 
reporting the use of this technique. Rather it has an important risk of de novo psychiatric 
syndromes and worsening of previous psychopathology, including not only depression but 
also psychotic and manic syndromes. Finally, we showed the need to include lifetime 
psychiatric history as a predictor of surgery outcome  
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We believe that our results appeal to the interest of psychiatrists, neurologists and 
neurosurgeons and more importantly may help to improve the care of people with RE. 
We also believe that this research could add information to the current knowledge of the 





The work presented in this thesis follows a coherent line of research in order to clarify the 
bidirectional relationship between mental disorders and refractory epilepsy.  
Some main conclusions may be drawn from our study. Firstly, there is a high prevalence of 
psychiatric disorders in people with refractory epilepsy and the right-sided epileptogenic 
zone seems to be a risk factor. Secondly, the lobe where the epileptogenic zone is located 
does have an influence on dysfunctional personality patterns of patients with ER and that 
surgery might have a positive impact on the improvement of these patterns. Thirdly, ANT-
DBS and a multilobar epileptogenic zone increase the risk of worsening of previous 
psychopathology, regarding certain symptom dimensions and de novo psychiatric 
syndromes. Fourthly, people with bilateral epileptogenic zones and those with Engel class 
II, in comparison to class I, suffer from higher psychological distress after surgery. These 
patients should be warned about these potential secondary effects and should also benefit 
from more frequent routine assessments.  
Fifthly, a history of any mental disorder is an important determinant of the success of surgery 
regarding the control of epileptic seizures and should be considered as an epilepsy surgery 
outcome predictor. Although mental disorders are not considered to constitute 
contraindications for surgery, we suggest that when deciding to proceed for surgery this 
variable should be taken in account.  
Overall these findings support the idea of a bidirectional relationship between psychiatry 
and refractory epilepsy and reinforces the need of the presence of psychiatrists in centers 
were RE patients are treated. Unfortunately, this is not the rule for many centers in the 
developed countries[14]. 
Future studies should include more robust samples to confirm our results. They should 
should focus in all kinds of psychiatric events and the aggravation of psychopathological 
symptoms after epilepsy surgery, and particularly, ANT-DBS and in the treatment options 
for these patients. The clarification of the hypothesis of a subgroup of patients with a more 
generalized dysfunction and a more serious neuropsychiatric disorders, as well as, the 




CONTRIBUTION OF THE CANDIDATE TO THE RESULTS OF THIS 
WORK  
 
The candidate was responsible for:  
 
• Evaluation and application of questionnaires and scales in part of the sample 
• Collection of all clinical data and building databases 
• Definition of all clinical hypothesis 
• Design of each study 
• Statistical analysis of all data 
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